Category: China

Posted on

China’s 15th Five-Year Plan: Charting Solutions in an Uncertain World

Source: Media Outreach

CGTN’s special feature explores potential impacts of China’s 15th Five-Year Plan beyond its borders.

BEIJING, CHINA – Media OutReach Newswire – 27 March 2026 – As policymakers and business leaders convene at the Boao Forum for Asia Annual Conference, one of the most closely watched gatherings on the global calendar, attention is turning to China’s national development blueprint: the 15th Five-Year Plan. Beijing’s latest development roadmap arrives at a critical moment, as the world is grappling with geopolitical tensions, economic fragmentation and climate change. With these challenges mounting, many international observers are exploring how this blueprint will shape future development trajectories within China and beyond.

China’s 15th Five-Year Plan Charting Solutions in an Uncertain World

Achim Steiner, former administrator of the United Nations Development Programme, regards green transition, which takes center stage in China’s 15th Five-Year Plan, as one of the defining economic shifts of the coming decades. He emphasizes that China’s leadership on renewable energy, ranging from solar panels to electric vehicles, have not only driven down global costs, but also turned technologies like EVs that were once considered “luxury and privilege” into accessible tools for people’s daily lives. He noted such a giant leap in green technology represents a frontline opportunity for transformation on the African continent, where over 600 million people still lack electricity. Steiner believes the green mindset adopted by Beijing will help many developing nations to avoid catastrophic fallout from climate change. And as certain western nations waver on climate commitments, China’s approach to addressing global warming, in contrast, provides a compelling model of a responsible nation, which suggests that green growth can be a policy priority and allow for win-win progress.

Mohd Faiz Abdullah, executive chairman of the Institute of Strategic and International Studies in Malaysia, situates China’s development strategy within a regional context. He says that the cooperation between China and ASEAN has been contributing to regional and global growth. He described the global economic status quo as “increasingly fragmented,” adding that the key challenge is “not to help one individual economy grow,” but to achieve shared and sustained prosperity “at regional and global levels.” Such a joint task requires shared responsibility in a variety of crucial areas covered in China’s 15th Five-Year Plan, including advanced manufacturing, green transition and technological upgrading. In his view, the development vision demonstrated in China’s 15th Five-Year Plan is not solely inward-looking, but also a domestic model that can convert to outward impact to the wider world. Abdullah also highlighted that China and ASEAN have already formed one of the world’s most dynamic economic partnerships, characterized by expanding investment flows and deepening integration. He believes that the continued implementation of the Regional Comprehensive Economic Partnership will ensure ASEAN and China can work together to achieve shared economic progress for the next decade.

Justin Yifu Lin, former chief economist for the World Bank, argues that while the global economy is mired in uncertainty and turbulence, China remains a rare source of stability, certainty and development momentum. Since about 2008, he noted, China has contributed roughly 30 percent of global growth, underscoring its role as a key engine of the world economy. Acknowledging that challenges are universal rather than unique to China, Lin stressed that what matters is the ability to recognize both constraints and opportunities, and to turn the latter into tangible growth. He pointed to China’s continued potential in technological innovation and industrial upgrading, supported by its large talent pool, vast domestic market, comprehensive manufacturing base and effective coordination between market forces and government policy. While external risks such as supply chain disruptions and trade tensions persist, alongside domestic pressures, including aging and regional development imbalance, Lin suggests China still holds significant growth potential, possibly around 8 percent per year through 2035, if these challenges are well managed.

In a world increasingly defined by uncertainty, China’s 15th Five-Year Plan is deemed as an important source of direction and momentum. As the country aims for a good start to its next five-year development period, seeking to advance modernization through high-quality development, major tasks still lie ahead.

Hashtag: #BoaoForumForAsia #ChinaEconomy #FiveYearPlan #GlobalGrowth #GreenTransition

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/chinas-15th-five-year-plan-charting-solutions-in-an-uncertain-world/

Posted on

Tech-Driven Restoration: Saving the World’s Critically Endangered White-headed Langur

Source: Media Outreach

  • Through decades of careful conservation efforts, the white-headed langur population has increased from just over 300 in the 1980s to more than 1,400 across 130 groups today.
  • An AI-powered system covers more than 20 monitoring stations in the Guangxi Chongzuo White-headed Langur National Nature Reserve. It has logged 37,200 detections of langur activity, which provide critical data for research and conservation.
  • To date, 77.6 hectares of habitat has been restored, 2 drinking water sources and 18 water drinking points for the langurs have been built, and 2 ecological corridors have been constructed.

CHONGZUO, CHINA – Media OutReach Newswire – 27 March 2026 – In the rugged karst mountains of Guangxi in Southern China, a primate species once on the brink of extinction – the white-headed langur – is steadily recovering in population thanks to a range of measures that bring together technology, law enforcement, and ecological restoration.

Found exclusively in Chongzuo, Guangxi, the white-headed langur is listed as Critically Endangered by the IUCN Red List of Threatened Species and the Red List of China’s Vertebrates. New monitoring data reveals that the “stone mountain elf”, which is even rarer than the giant panda, is no longer on the brink of extinction. Through the combined efforts of the local government, the nature reserve, academia, and the tech sector, the survival crisis triggered by habitat fragmentation has been significantly reversed for this species.

To address the challenges posed by the rugged karst terrain and the difficulties of traditional patrol and monitoring, the nature reserve teamed up with Huawei and the China-ASEAN Artificial Intelligence Application Cooperation Center to develop an intelligent monitoring platform powered by AI computing. Thanks to the video-based animal monitoring devices deployed along the cliffs, the system can collect real-time data on the langurs’ distribution, surroundings, and patterns of activity. Using AI-driven automated labeling and data analytics, the reserve has developed a complete dashboard for visualized management. This has significantly enhanced the efficiency of data retrieval and analysis. To date, the system has recorded over 37,200 instances of langur activity.

In addition to technical support, innovation in ecological protection and restoration mechanisms is also critical. The Chongzuo White-Headed Langur Habitat Protection Regulations, the first regulation of its kind in China, forms the legal framework for the reserve’s protection efforts. Under this framework, a range of measures has been implemented. To date, 77.6 hectares of habitat has been restored, 2 drinking water sources and 18 water drinking points for the langurs have been built, and 2 ecological corridors have been constructed. The white-headed langur population has increased to more than 1,400 across 130 groups. As the langur is an umbrella species of the local karst ecosystem, the growth of its population is critical to the region’s biodiversity. Wild duck lettuce, a level-II protected species in China, was recently found in the reserve for the first time, a sign of recovery in the fragile local ecosystem.

Nong Dengpan, Director of the Guangxi Chongzuo White-headed Langur National Nature Reserve Management Center, said: “The growth of the white-headed langur population can be attributed to a combination of technology, legislation, and ecological restoration efforts. Digital technology enables more precise observation of these limestone langurs and more informed management of their living environment. This integrated conservation model can serve as a reference for the protection and population recovery of other endangered primate species, such as the eastern black crested gibbon in Southeast Asia.”

Tian Yongsheng, Deputy General Manager of Huawei Guangxi, noted: “Huawei is committed to conserving nature with technology. We work with global partners to support ecosystem conservation using digital technologies like 5G, cloud, and AI. The success of the white-headed langur project demonstrates AI’s immense value in processing complex geographical data and massive volumes of species data. We will continue using innovative technologies to protect biodiversity and enable the harmonious coexistence of humanity and nature.”

By the end of 2025, our digital inclusion projects for environmental protection had been implemented in 65 protected areas around the world. These projects have significantly improved the efficiency of biodiversity conservation and the sustainable use and management of natural resources.

Hashtag: #Huawei

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/tech-driven-restoration-saving-the-worlds-critically-endangered-white-headed-langur/

Posted on

Voicecomm Technology (02495.HK) Announces 2025 Annual Results

Source: Media Outreach

High-Quality Growth with Improved Gross Profit Margin, increasing R&D Investment and Strategic Focus on Trustworthy Agents Ecosystem

HONG KONG SAR – Media OutReach Newswire – 27 March 2026 – Voicecomm Technology Co., Ltd. (“Voicecomm Technology” or the “Company“, Stock Code: 2495.HK), a core technology provider and ecosystem operator of trustworthy conversational AI in China, announced its annual results for the year ended December 31, 2025. Leveraging its deep technological expertise and forward-looking strategic initiatives in trustworthy conversational AI, the Company achieved steady revenue growth, continuous improvement in profitability, and a significant enhancement in operating cash flow, further strengthening its competitive edge in the enterprise-level trustworthy Agent sector.

Gross Profit Margin Steadily Improves, Operating Cash Flow Turns Strongly Positive

In 2025, the Company’s total revenue successfully exceeded the RMB1 billion mark, reaching RMB1,006.9 million, representing a year-on-year increase of 7.0%. Gross profit amounted to RMB551.2 million, increased by 8.0% from the previous year, while the gross profit margin increased by 0.5 percentage point to 54.7% from 54.2% in the same period last year, reflecting the high-value-added products and technical services of the Company, as well as effective cost control.

Notably, the Company’s net cash generated from operating activities turned strongly positive, reaching a net inflow of RMB212.5 million, compared to a net outflow of RMB129.2 million in the same period last year. This improvement underscores enhanced operational efficiency and reflects strengthened receivables management, which accelerated cash collection.

Profit for the year amounted to RMB140.2 million. The significant increase in net profit compared to the same period last year was mainly attributable to eliminating the impacts of changes in carrying amount of redeemable capital contributions, an accounting adjustment arising from financing agreements entered into with shareholders prior to the Listing and completion of the Global Offering.

Increasing R&D Investment to Strengthen the Trustworthy Agent Technology Foundations

As a technology-centric product company, Voicecomm Technology remains committed to the independent R&D and innovation of underlying technologies. In 2025, the Company’s research and development expenses reached RMB224.3 million, representing a substantial year-on-year increase of 67.7%. The investment was primarily directed towards developing Agents with continuous learning capabilities and a technical framework for Multi-agent collaboration, aiming to enhance technological capabilities and elevate the level of product innovation. This reinforces our trustworthy Agent technical architecture composed of three layers: “Multimodal Perception + Multi-model Thinking + Multi-agent Collaboration”.

This architecture takes the “meta-model” as the core to effectively alleviate the common pain points of in enterprise-level implementation, such as hallucinations, controllability and data security, by integrating the generalization capabilities of large language models with the precision of vertical domain knowledge. On this basis, the Company have formed a deliverable and operable trustworthy Agent product system, to ensure that the Agents are usable, manageable, and controllable in enterprise environments, thereby powering the intelligent upgrade of six core application scenarios: City management and administration, Automotive and transportation, Telecommunications, Finance, Healthcare, and Energy management.

Productization Strategy Drives Deep Application across Six Core Scenarios

Voicecomm Technology focuses on empowering various industries through superior products and technologies. In 2025, leveraging its mature product matrix, the Company successfully established replicable benchmark standards across multiple application scenarios.

City Management and Administration: As a leading solution provider in the smart government sector in China, the Company’s business has covered more than 130 prefecture-level cities. The “Smart Government Agent” deeply integrates the capacities of large language models, enabling more intelligent and automated government services with standardized and intelligent applications in scenarios such as government hotlines and city governance.

Automotive and Transportation: The Company successfully established benchmark autonomous driving projects in cities such as Mianyang, Zibo, and Ezhou, building a successful and replicable “Smart Transportation Agent” solution. For the Mianyang Science and Technology New City project, a total of 96 autonomous vehicles have been deployed, and the project was successfully selected as a National AI Application Pilot Testing Base in the transportation sector. In January 2026, the Company newly won the bid for the “Ezhou Huahu Airport Smart Port” autonomous driving bus procurement and operation project, further expanding its application boundaries.

Healthcare: In January 2026, the Company successfully won the bid for the “Chuannan Smart Valley AI Vertical Large Model Innovation Platform – Silver Economy Construction and Operation Project” in Neijiang City, Sichuan Province, with a total contract value of nearly RMB300 million. This project represents the Company’s first “AI + Elderly Care” city-level benchmark demonstration project. It adopts a closed-loop collaborative model of “online platform + offline service network + home terminals,” integrating Agents capabilities with the Company’s “vertical small model microservices” system in areas such as Health Early Warning, Cognitive Ability Assessment, and emotional companionship into a productized solution, thereby establishing rapidly replicable city-level smart elderly care operational benchmark.

Telecommunications, Finance, and Energy Management: The Company continues to deepen collaborations with leading enterprises in the telecommunications and finance sectors, leveraging the “Telecommunication Service Agent” and “Financial Service Agent” to enhance service efficiency and user service value. Meanwhile, its AI-powered smart charging solution has been progressively integrating charging pile networks in China and across several Southeast Asian countries.

Benefiting from the successful implementation of the Company’s productization strategy and the high level of market recognition for its trustworthy Agent solutions, as of December 31, 2025, the Group’s project pipeline and orders in hand saw significant growth. The number of ongoing projects at year-end increased to 320, representing a year-on-year increase of 41.6%, while the outstanding contract sum at year-end rose to RMB1,048.9 million, a year-on-year increase of 57.4%, reflecting the continued expansion of the Company’s business.

Future Outlook: Focusing on the Trustworthy Agents Ecosystem with Four Strategic Priorities

Looking ahead, the Company will firmly focus on its goal of “building a trustworthy conversational AI ecosystem” and will advance the following strategic priorities:

Overall and Technology Strategy: Continue to focus on R&D and innovation in frontier technologies such as multi-modal fusion and trustworthy intelligence, promoting the deployment of trustworthy agents across more application scenarios. By creating open technology platforms and standards, the Company will attract more developers and partners to jointly build a prosperous and win-win industrial ecosystem.

Market Strategy: Establish benchmarks for quality and innovation within the industry and deepening partnerships with various service channels. At the same time, the Company will actively expand into the C-end market, extending cutting-edge technologies to a wider user base, thereby expanding the influence and commercial value of the ecosystem.

Regional Strategy: Domestically, the Company will continue to deepen its partnerships with major cooperating cities to create smart city benchmark cases. Internationally, the Company will actively respond to the “Belt and Road” initiative, grasp the tremendous potential of emerging markets, and promote the Company’s trustworthy Agent products and services globally to enhance its international brand image.

Investment Strategy: Through prudent strategic investments and M&A, the Company will optimize the layout of the upstream and downstream industry chains and consolidate the stability and competitiveness of the ecosystem.

DR.Tang Jinghua, Chairman ofVoicecomm Technology Co., Ltd., said: ” 2025 was a landmark year for Voicecomm Technology. We not only achieved a strong turnaround in operating cash flow and a steady increase in gross profit margin financially, but we also completed a strategic leap at the technological and business level towards becoming a ‘a core technology provider and ecosystem operator of trustworthy conversational AI.’ We deeply understand that the essence of enterprise-grade AI lies in creating replicable and reliable products and technology foundations. During the year, we significantly increased R&D investment and successfully applied our trustworthy Agents across six core scenarios, particularly in city-level benchmark projects in emerging fields like smart elderly care, showing the strong competitiveness of our productization strategy. Looking to the future, we will continue to pursue the goal of ‘building a trustworthy conversational AI ecosystem,’ leveraging an open platform to gather ecosystem partners and empowering diverse industries with innovative technology, thereby creating long-term sustainable value for our shareholders and society. “

Hashtag: #Voicecomm

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/voicecomm-technology-02495-hk-announces-2025-annual-results/

Posted on

Bridging the Digital Divide: 5G Drives Rural Revitalization in Guangxi, China

Source: Media Outreach

CHONGZUO, CHINA – Media OutReach Newswire – 26 March 2026 – In the karst terrain of Guangxi Zhuang Autonomous Region, Buhua Village, once a remote and economically underdeveloped community, has been transformed into a popular tourist attraction thanks to a 5G information superhighway co-built by China Mobile and Huawei. This digital leap has established the village as a model of rural revitalization, generating over CNY500,000 in annual collective village income and boosting per capita annual earnings by CNY18,000.

Chongzuo is characterized by impressive karst landforms with peak clusters and peak forests. This breathtaking terrain presents huge challenges for communications network buildout. To overcome these geographic barriers, China Mobile and Huawei have collaborated on technological innovations in a bid to achieve comprehensive network coverage. Today, all administrative villages in Chongzuo have access to 5G networks, while 99% of its natural villages have 4G coverage and 94% have 5G coverage.

Buhua Village is within the jurisdiction of Chongzuo City. The village upgraded its networks from 4G to 5G as early as 2021, offering residents digital services on par with those seen in major cities. The deployment of advanced communications networks has catalyzed the growth of Buhua’s distinctive local industries.

In Xinhe Town, where the village is situated, a digital e-commerce ecosystem has been established, featuring 65 product stores on platforms like JD.com and Douyin, which are collectively owned by the village. Furthermore, a live-streaming incubation base has been established, nurturing 27 local live streamers. These stores secure over CNY300,000 in revenue each year by selling local specialties like Buhua brown sugar. This is a handcrafted product that is recognized as intangible cultural heritage, with a 150% price premium over normal brown sugar. It is sold to tier-1 cities in China, like Beijing, Shanghai, and Guangzhou, and is even exported overseas, including to Japan and South Korea.

Digital technology is also driving the upgrade of the local tourism industry. China Mobile has established an intelligent ticketing system at the Heishui River, which is Buhua Village’s most popular scenic spot where activities like rafting, boat tours, and paddleboarding are available for tourists. This system has reduced the average time for tourists to purchase tickets from 20 minutes to just 3 minutes, with online purchases now accounting for 30% of the total. Accommodation can also be booked through the system, which has increased the booking rate of local homestays by 30%.

Digitalization has further expanded to the ecological protection field. A safety monitoring and IT system project for modern irrigation engineering along the Heishui River has been launched, with investment totaling CNY100 million. Supported by the Bianjiang Zhizhou open AI platform, the digital monitoring system is set to cover 13 towns across four counties/districts in Chongzuo. Once up and running, it will enable the integrated, real-time monitoring of water quality and other ecological parameters of the Heishui River, and intelligently issue early warnings to guarantee safe water irrigation across 60,000 hectares of farmland in the river basin.

Digitalization has helped Buhua Village make the jump from poverty to prosperity. In 2025, the village’s annual collective economic income (generated from assets, land, or enterprises owned by the village community rather than individuals) exceeded CNY500,000. The average income of every household reached over CNY80,000, three times the average income from traditional sugarcane farming. The annual per capita income of villagers increased by CNY18,000. As a result, an increasing number of young people have chosen to return to the village and develop their careers.

Zhou Peng, General Manager of China Mobile Guangxi’s Chongzuo Branch, said, “By bridging the digital divide, we are helping remote villages like Buhua develop digital trade alongside traditional agriculture. This is transforming resources that were not fully used in the past due to geographical limitations into strong momentum for economic growth in the digital age.”

Tian Yongsheng, Deputy General Manager of Huawei Guangxi, noted, “Huawei is supporting China Mobile in building a solid digital foundation for Chongzuo with innovative solutions. We look forward to seeing technology overcome geographical limitations and enable more remote villages to achieve leapfrog development in the 5G and AI era.”

Hashtag: #Huawei

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/bridging-the-digital-divide-5g-drives-rural-revitalization-in-guangxi-china/

Posted on

Ping An Digital Bank Embarks on a New Journey

Source: Media Outreach

“Always with You, Always Ahead,” From banking services to life protection planning, professionally supports your journey with peace of mind

HONG KONG SAR – Media OutReach Newswire – 26 March 2026 – Ping An Digital Bank (International) Limited (“Ping An Digital Bank” or “PingAnDB”) unveils its new branding today. As one of the integrated financial platforms in Hong Kong under Ping An Insurance (Group) Company of China, Ltd. (“Ping An”; SEHK: 2318; SSE: 601318), Ping An Digital Bank leverages the Group’s technology integrated strength to embark on an exciting new chapter.

With a core commitment to enhancing customer experience, Ping An Digital Bank adheres to its vision of “Always with You, Always Ahead.” Harnessing innovative technology, the Bank redefines the digital banking journey, making it simpler for customers to manage their deposits, investments, and insurance – all from a single account from their mobile device. Striving to anticipate customer needs and go the extra mile, Ping An Digital Bank empowers customers to take smarter steps towards financial growth and accumulate wealth steadily over time, without the burden of complex procedures or heavy research.

Mr. Ronald Iu, Chief Executive of Ping An Digital Bank, said, “We are delighted to unveil a brand new Ping An Digital Bank. This better reflects our deep connection with Ping An Group, integrating our signature ‘insurance DNA’ directly into our banking services and further reinforcing our role as an integrated financial platform in Hong Kong. Moving forward, Ping An Digital Bank will continue to develop both retail and business banking. Our team is dedicated to our brand vision of ‘Always with You, Always Ahead’ as our brand image transforms – building trust as the foundation, and simplicity as our priority. From banking to life protection planning, our professional team stands ready to support our clients throughout every stage of their financial journey.”

Retail Banking: User-Centric at the Core
One Account for Deposits, Investments & Insurance
Since joining Lufax in 2024, Ping An Digital Bank has accelerated the development of its retail banking offerings, launching online and offline insurance, as well as wealth services. With one single account that integrates deposits, foreign exchange, cross-border remittances, wealth and insurance, customers can now enjoy truly one-stop financial experience. As of 15 March 2026, total retail banking deposits have surpassed HK$ 12 billion.

With user-friendliness at the heart of its design, Ping An Digital Bank’s retail banking services aim to minimise redundant steps and simplify money management. The latest dual-advantage wealth solution marries the experience of agility of a brokerage with the security of a bank, allowing customers to invest in Hong Kong stocks, U.S. stocks, funds, and money market funds directly from their savings accounts with no extra transfers required, enabling customers to SWITCH flexibly between investment and deposit services.

Powered by Ping An’s robust insurance pedigree, Ping An Digital Bank leads the market as Hong Kong’s first digital bank to provide a full spectrum of online and offline insurance services. For unrivalled efficiency, customers can purchase general insurance products, including motor insurance, travel insurance, and home insurance products, online within minutes. For client-centric experience with human touch, the Bank’s offline platform delivers an extensive range of life protection and savings plans, tailored to each client’s needs.

Business Banking: A Pillar of Support for Trade Enterprises
Driving Breakthroughs with Data & Technology
As a leading digital bank for SMEs in Hong Kong, Ping An Digital Bank plays a pivotal role in supporting the city’s trading enterprises. By harnessing advanced technology and business data, the Bank is striving to help unleash the full potential of Hong Kong’s digital economy while backing the HKSAR Government’s vision for smart city development. Through the integration of trade, logistics, and financial data, Ping An Digital Bank is revolutionising the credit approval process to deliver quicker and more flexible assessments, empowering a broader range of businesses to seize new opportunities.

From account opening and foreign exchange to cross-border remittances and financing, Ping An Digital Bank stands as a key pillar of support for trading enterprises, providing an integrated business banking suite that meets the practical needs of companies in both daily operations and international expansion. Leveraging innovative data models, the Bank empowers trading SMEs to advance their operations and thrive, and thus becoming a dedicated and trusted partner for business growth.

Looking ahead, Ping An Digital Bank will continue to put customer convenience at the heart of its services, striving to help both individuals and businesses to save time, effort and cost. The Bank is dedicated to setting new benchmarks for digital banking, while reinforcing its position as a key pillar within Ping An Group’s integrated financial platform in Hong Kong.

Investment involves risk. The price of investments fluctuates, sometimes dramatically. The price of investments may move up or down, and may become valueless. There is an inherent risk that losses may be incurred rather than profit made as a result of buying and selling investment products. Foreign investments carry additional risks not generally associated with the domestic market. You should carefully consider whether any investment products or services mentioned herein are appropriate for you in view of your investment experience, objectives, financial resources and circumstances.

Hashtag: #PingAnDigitalBank #平安數字銀行

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/ping-an-digital-bank-embarks-on-a-new-journey/

Posted on

WRISE Group Partners with China Asset Management (Hong Kong) to Offer Exclusive Access to Asia Bond Fund high dividend yield share class in Hong Kong Debut

Source: Media Outreach

  1. WRISE Prestige is the first firm in Hong Kong to offer the ChinaAMC Select Asia Bond Fund (Income Share Class), marking a milestone partnership that reinforces its standing as a leading wealth management firm.
  2. The Fund’s Income share class * offers a target dividend yield of approximately 9%, combining strong historical performance with flexible, benchmark-unconstrained allocation to meet growing demand for income-generating solutions in Asia.
  3. The partnership underscores WRISE’s commitment to expanding its curated suite of institutional-grade investment solutions for sophisticated investors across the region.

HONG KONG SAR – Media OutReach Newswire – 26 March 2026 – WRISE Group (“WRISE“), one of Asia’s fastest-growing independent wealth management firm, announced that WRISE Prestige, has established a strategic partnership with China Asset Management (Hong Kong) Limited (“ChinaAMC (HK)“), one of the region’s most established asset managers. Through this collaboration, WRISE Prestige will serve as the first launch partner in Hong Kong with a period of exclusive access to the ChinaAMC Select Asia Bond Fund (INC share class), offering clients a compelling fixed income solution designed for yield and diversification. To mark the partnership and the launch of the exclusive share class, WRISE Prestige and ChinaAMC (HK) co-hosted an event yesterday to formally announce the collaboration and introduce the investment strategy behind the ChinaAMC Select Asia Bond Fund to invited guests and clients.

The ChinaAMC Select Asia Bond Fund adopts a flexible, benchmark-unconstrained investment approach, allowing the fund manager to capitalise on opportunities across Asian credit markets dynamically. By focusing on fundamentally sound issuers, with a particular emphasis on China and the broader Asian region, the Fund seeks to deliver attractive risk-adjusted returns. Its strong historical track record underscoring the robustness of its investment process.

Recent geopolitical tensions have triggered significant volatility across global financial markets, making diversified, income-oriented strategies that can navigate geopolitical uncertainty paramount for sophisticated investors seeking portfolio resilience. With a target dividend yield of approximately 9%*, the Fund’s Income share class is positioned to address the increasing demand among Asian investors for stable and sufficient cash flow solutions. This income-focused strategy complements the broader portfolio needs of high-net-worth individuals seeking resilience and yield beyond traditional asset classes.

Henry Shin, Chief Executive Officer of WRISE Prestige, said: “We are delighted to partner with ChinaAMC to bring the ChinaAMC Select Asia Bond Fund (Income Share Class) to our clients as an exclusive launch in Hong Kong. In today’s volatile geopolitical landscape, investors require solutions that can adapt to changing conditions while delivering consistent income. The ChinaAMC Select Asia Bond Fund embodies this approach, offering flexible mandate and strong yield potential that make it a valuable addition to our curated platform.”

Barney Gao, Head of Strategic Client Development at China Asset Management (Hong Kong), said, “We are pleased to collaborate with WRISE Prestige to introduce the ChinaAMC Select Asia Bond Fund (Income Share Class) to investors in Hong Kong. This partnership reflects our commitment to delivering innovative and performance-driven investment solutions to a broader audience. With its focus on Asian bond markets and a flexible investment strategy, the Fund is well-suited to meet the income and diversification needs of investors in the region.”

This partnership highlights WRISE’s ongoing strategy to broaden access to best-in-class asset managers and deliver tailored investment solutions that address the complex and evolving needs of private wealth clients across Asia.

Important Information

This document is issued by WRISE Prestige Securities Limited (CE No. BSJ229). This document is for information purposes only and does not constitute and should not be construed as an offer, solicitation, recommendation or advice to buy or sell any investment product, nor should it be regarded as investment research.

Investment involves risks. The value of investments may go down as well as up and investors may not get back the principal invested. Past performance is not indicative of future performance.

The ChinaAMC Select Asia Bond Fund is authorized by the Securities and Futures Commission (“SFC”) in Hong Kong. SFC authorization is not a recommendation or endorsement of the Fund nor does it guarantee the commercial merits of the Fund or its performance. It does not mean the Fund is suitable for all investors.

Distributions (if any) are not guaranteed. Distribution rates are not indicative of the Fund’s return. The Fund may pay distributions out of income and/or capital (or effectively out of capital), which may result in an immediate reduction of the Fund’s net asset value.

This document has not been reviewed by the SFC.

* The Manager may at its discretion pay dividend out of capital or effectively out of the capital of the Funds. Payment of dividends out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any such capital gains attributable to that original investment. Any such distributions may result in an immediate reduction in the Net Asset Value per Unit.

Hashtag: #WRISE

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/27/wrise-group-partners-with-china-asset-management-hong-kong-to-offer-exclusive-access-to-asia-bond-fund-high-dividend-yield-share-class-in-hong-kong-debut/

Posted on

Nonstop in 11 Hours to the “City of Pandas”: Chengdu Launches Direct Flights to Brussels

Source: Media Outreach

CHENGDU, CHINA – Media OutReach Newswire – 26 March 2026 – Air China launched a direct passenger flight from Chengdu to Brussels, the capital of Belgium, with service starting March 26. This marks Chengdu’s 12th regular direct passenger route to Europe. The inaugural flight recorded a load factor of 95%, with the return leg reaching 85%, underscoring strong market demand.

Chengdu Tianfu International Airport

According to Air China’s Southwest Branch, the Chengdu (Tianfu International Airport)-Brussels route offers three round trips per week on the Airbus A330-300, with flights scheduled on Tuesdays, Thursdays, and Sundays. Previously, Chengdu had already opened a dedicated all-cargo route to Brussels. The launch of the passenger service now establishes a dual-track system for both passenger and freight transport.

Before the route’s launch, travelers from Chengdu to Brussels typically required a transfer, with the whole journey taking more than 17 hours. The new direct service cuts travel time to under 11 hours, creating a faster and more convenient aerial corridor for economic and trade cooperation, cultural exchange, and people-to-people connectivity between China and Belgium.

This route also represents Chengdu’s first newly launched intercontinental passenger service of the year. To date, the city operates 19 intercontinental passenger routes, including 12 connecting major European cities such as Frankfurt, London, Paris, and Brussels, with nearly 40 weekly flights. Chengdu’s regular international and regional direct routes have now clocked up 85, markedly boosting its global connectivity.

The ever-expanding international flight network has further stimulated inbound tourism. In 2025, Chengdu received 2.38 million inbound tourists, a year-on-year increase of 44.3%, signaling a strong recovery of the inbound tourism market. During the recent 2026 Spring Festival, the city welcomed 77,000 inbound tourists, up 47.2% year on year, with a growing number of international travelers choosing Chengdu as their top destination for experiencing China.

As noted by The Times in its feature on 12 of the Best Places to Visit in China: “Home of the Chengdu Research Base of Giant Panda Breeding, this city has become a popular stop on many China tours. Foodies will relish their visit—it’s one of the original UNESCO cities of gastronomy, so you’ll find the best of Sichuan cuisine here. Highlights include spicy hotpot, mapo tofu, and the myriad street foods you’ll find outside Chengdu’s many temples. It’s also the departure point for tours to the national parks of Jiuzhai Valley and Huanglong, and the autonomous regions around Sichuan.”

To enhance the travel experience of international passengers, Chengdu has introduced a package of measures covering tax refunds upon payment, language services, smart navigation, and promotional incentives, all aimed at improving convenience and adding to the appeal of inbound tourism. Policies such as instant tax refunds, direct payments via overseas e-wallets, and over 600 tax refund stores have largely facilitated travel for international tourists.

In 2025, Chengdu had more than 6,000 taxi drivers trained in English, and the scenic area Xiling Snow Mountain rolled out an international booking platform supporting real-time translation in 24 languages and transactions in 29 currencies, with multilingual AI translation screens installed across major tourist attractions and transportation hubs in Chengdu.

Meanwhile, Jinli Street—once named by CNN as one of the world’s most beautiful streets—officially introduced the “Open Chengdu” cultural tourism base on February 6. The base features a professional English-language service team, more than 300 bilingual signs, and over 10 bilingual self-service ticketing machines supporting multiple ID types. Across more than 50 locations in Jinli, from museum gift shops to street vendors, international credit cards such as VISA are widely accepted.

In addition, Chengdu Eastern New Area, where Chengdu Tianfu International Airport is located, offers international transit passengers subsidies of up to 400 yuan per person, including 200 for hotel stays, 100 for consumption vouchers, and 100 for railway tickets.

Hashtag: #ChengduInformationOffice

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/nonstop-in-11-hours-to-the-city-of-pandas-chengdu-launches-direct-flights-to-brussels/

Posted on

Opening remarks – Otago Tourism Policy School

Source: New Zealand Government

Tēnā koutou katoa. Good afternoon, everyone. 

Thank you, Mayor John Glover, for your opening remarks, and thank you Associate Professor Susan Houge Mackenzie for convening this important event.

It’s a pleasure to be at the 2026 Otago Tourism Policy School here in Queenstown.

Queenstown captures so much of what makes New Zealand distinctive as a destination – our landscapes, our hospitality and our appetite for innovation. 

It’s an ideal place to come together for an important event on the annual tourism calendar.

When I spoke at this event last year, I announced Round Two of the Regional Events Promotion Fund. This Fund was designed to grow visitation beyond the main centres and outside peak season.

12 months on, I’m delighted to report that across two rounds, the Fund has supported more than 280 regional events. That announcement was the beginning of what has been an exciting year for tourism and hospitality.

Overall, tourism growth has been really encouraging over the past 12 months and we’re looking forward to that continuing. 

I now want to briefly address a topic which I know is top of mind for many in the sector – the current conflict in Iran. 

I’m being kept closely informed through the work of the Government’s Ministerial oversight group and by advice from agency officials. 

I can assure you that along with my Ministerial colleagues, I’m carefully monitoring the situation. This includes for the tourism portfolio and also for wider cost of living implications for New Zealanders.

During the ongoing situation, other flight routes, including those through the Americas and different parts of Asia, do continue to be available and visitors continue to come to New Zealand.

Additionally, and as we know the Middle East is a critical aviation hub, it’s been encouraging to see a resumption of flights on the route, with ultra-long haul routes like Auckland prioritised.

My priorities

The theme of this year’s Otago Tourism Policy School: What should tourism look like in 2050? aligns well with my own priorities.

In June last year, I launched the Tourism Growth Roadmap with two clear priorities: 

One:  growing international tourism – by increasing visitor numbers in the short term and doubling the value of tourism exports by 2034. Tourism is our second‑largest export, contributing 7.7 per cent of GDP. 

Growth in this sector is central to the Government’s wider economic objectives. It means more spending in our regions, bookings in our hotels, full tables in our cafes and restaurants and more jobs created. 

Two:  growing the number of New Zealanders working in tourism and hospitality. The latest Tourism Satellite Account shows one in nine jobs are now supported by tourism and hospitality – a clear signal of the sector’s importance to employment and regional prosperity.

Delivering on these priorities requires partnership across central government, industry, local government, iwi and communities to ensure growth delivers value for visitors and residents alike.

Since launching the Roadmap, we’ve focused on boosting demand, while also undertaking a review of the tourism system to understand where supply‑side constraints and opportunities lie. This Review has been shaped by extensive engagement with the sector, including many of you here today.

So, this year’s theme What should tourism look like in 2050?  absolutely aligns with this work. 

It challenges us all to think long‑term, towards a system that can sustain growth over decades. 

Achievements since launching the Roadmap – boosting demand

International arrivals are now at around 90 per cent of 2019 levels[1] and latest data from the Tourism Satellite Account shows total tourism expenditure at $46.6 billion for the year ending March 2025. 

We’ve also made progress on removing barriers to travel, further boosting visitation. Since the introduction of the visa‑free pathway for Chinese and Pacific travellers via Australia in November, nearly 59,000 requests have been approved, with more than 47,000 arrivals already recorded. 

Major Events and Tourism Package

In September, our Government launched the $70 million Major Events and Tourism Package, designed to drive economic growth and boost international visitor numbers.

This includes the $40 million Events Attraction Package to secure high‑impact events for New Zealand.

As a result, we’re now welcoming global events such as Robbie Williams, Linkin Park, the FIFA World Series, the World Surf League Championship Tour and Ultra Music Festival– with more to come.

We’ve also been working hard to deliver the Events Boost Fund, which has so far supported 34 new and existing events nationwide. 

We’ve continued investing in initiatives to drive outcomes in our regions. 

Round Two of the Regional Tourism Boost has now delivered nearly $10 million to campaigns across New Zealand. Collectively, the nine funded campaigns will attract global visitors, including from Australia, China, Canada and the United States.

The Boost provides a great example of the benefits to be realised when tourism and hospitality collaborate at scale. 

Hospitality is a huge contributor to our economy and workforce, helping drive over $9 billion in GDP and employing people across the country. 

As we attract more international visitors, the flow-on benefits for our hospitality sector become immediate and significant, as well as for our wider economy.

And of course we can’t forget the recent opening of the New Zealand International Convention Centre. What a wait it’s been but an enormous milestone and the benefits for New Zealand will be profound. 

2026 Hospitality Summit

Earlier this month, I hosted the 2026 Hospitality Summit, which brought hospitality associations and businesses together to engage with government and refresh shared priorities for the sector.

Recent progress made demonstrates the positive impacts on economic growth when government, business and communities work together. 

Michelin Guide 

A key recommendation from the 2024 Summit had been to bring the Michelin Guide to New Zealand, and that dream is now a reality. The inaugural Guide will be released in June, covering Auckland, Wellington, Christchurch and Queenstown.

This is a truly significant opportunity to celebrate our top talent and draw even more international visitors to our shores, further lifting hospitality activity and spending. 

Tourism New Zealand will leverage this with an increased focus on food and beverage in its marketing.

Achievements – Supply-side 

Our Government is committed to economic growth, and tourism is central to that mission.

New Zealand has significant capacity to support further tourism growth, but we know capacity isn’t evenly distributed. 

Growth must be managed in ways which protect destinations and the unique visitor experience they curate.

That’s why I’m taking a balanced approach – continuing to invest in demand-side initiatives which boost visitor numbers, while also stepping up investment in the supply side of the sector. 

This year, IVL investment is looking to prioritise 60 per cent towards demand initiatives and 40 per cent towards supply. 

I look forward to sharing my 2026/27 IVL investment plan in the coming months.

New Zealand Cycle Trails Investment

Investment in our cycle trails continues to deliver really strong returns. 

Over the past year, I’ve announced four investments in cycle trail upgrades through the Major Events and Tourism package. 

This includes $2 million to extend the Dunedin Tunnels Trail and attract more people through the beautiful Otago region we’re enjoying today.

Each year, more than two million people use the Great Rides, contributing an estimated $1.28 billion to regional economies. 

This is exactly the kind of infrastructure we need — supporting both domestic and international growth and enhancing visitor experience.

Tourism System Review

Alongside these investments, I’ve been undertaking a Tourism System Review. I’d like to thank those of you who’ve provided valuable input into this review so far and shared ideas about how we deliver on the objectives of the Tourism Growth Roadmap.

I’ve heard the message from the sector loud and clear: the status quo won’t support long‑term, sustainable growth. Three themes have come through strongly. 

First, clear national leadership.

Our system is fragmented with overlapping roles, multiple funding mechanisms and limited coordination beyond international marketing. This weakens our ability to deliver value and compete as a destination at an international scale.

Tourism presents significant opportunities for New Zealand, but I can see that without a more coordinated and forward-looking system, our full potential won’t be realised.

Second, a more streamlined regional model.

There is an opportunity to achieve greater coordination while retaining strong local voices. Better regional scale can support dispersal, manage seasonality, and lift value per visitor – while still recognising that many core functions must remain at place.

Initiatives like the Regional Tourism Boost are a great example of the benefits to can be realised when we collaborate at scale. I’m open to suggestions on how we can support regions to continue to collaborate to maximise outcomes for communities and visitors. 

While efficiencies can be gained, many of the key functions in our tourism system are, and must continue to be, delivered at place.

Local government’s role in placemaking remains essential. Events, museums and galleries, public spaces and visitor infrastructure are foundational to tourism. 

I’ve had some questions from councils about what the Government’s reforms to focus councils on core services and keep rates increases under control mean for their role in tourism. 

Councils absolutely have a role in ensuring our cities, towns and districts are great places to visit, and that tourism and hospitality businesses can thrive as a result. 

The local government reforms don’t change councils’ important role in that.

To meet our long-term growth objectives, it’s essential any changes to the tourism system ensures local government investment in tourism is maintained into the future. 

There’s no replacement for local insights, expertise and passion. This is precisely what makes our tourism offering distinct and valued, and this must be honoured as we consider our next steps.

Third, sustainable, long-term investment to support a growing tourism sector. 

This isn’t just about public investment, but creating the right settings and providing confidence for private investors.

Short‑term, reactive funding makes it difficult to align activity to long‑term priorities. 

We need greater certainty – for both public and private investment – and a system reflecting tourism’s status as a strategic national asset

From Roadmap to system reform:  Tourism Policy Statement 

Everything I’ve spoken about today – boosting demand, strengthening supply, investing in regions and reviewing the tourism system – has been deliberate and sequenced.

The Tourism Growth Roadmap was about stabilising and growing the sector after a period of disruption. Our demand investments focued on recovery and momentum, and our supply‑side shift has been about supporting capacity, quality and resilience.

The Tourism System Review has tested whether the way our system is structured is fit for the future. That work now brings us to the next step.

Following the Tourism System Review, I’m progressing a Tourism Policy Statement for New Zealand. This is the key announcement I want to leave with you today.

The Tourism Policy Statement will not be a reset, and it is not a stand‑alone document.

It is the next phase of the work underway, translating the Roadmap and the Review into a clear, enduring framework for how tourism is governed, coordinated and invested in over the long-term.

At its core, the Tourism Policy Statement will do three things

First, it will set a clear national direction for tourism. 

It will articulate tourism’s role as a strategic national asset and provide a shared narrative for government, local authorities, iwi and industry about what success looks like – not just in terms of volume, but in value, resilience and community benefit.

Second, it will provide clarity on roles, coordination and investment, both now and in the future

It will respond directly to what we heard through the Tourism System Review about fragmentation, duplication and short‑term funding. The Policy Statement will signal where leadership sits, how coordination should improve across the system, and where public investment (including the IVL) can best unlock long‑term value.

Third, it will give confidence to regions and industry.

By setting out priorities and expectations, the Policy Statement will provide a stronger basis for local government, regional entities and the private sector to plan, invest and collaborate with greater certainty.

This is about moving from a system evolving over time to one that is designed deliberately. This will support growth, protect place and deliver value for both visitors and New Zealanders.

I expect to release the Tourism Policy Statement in Q2 this year. In the meantime, I encourage you to continue engaging through your industry and professional associations. The quality of the thinking in this room is exactly what will strengthen this next phase.

Closing

As a Government, we know the strength of our tourism industry is clear for all to see – and the sector is certainly a key part of National’s plan to fix the basics and build the future. 

Under our watch, New Zealand is open for business and international visitors are returning.

While tourism has always been one of New Zealand’s strengths, its future success will not be accidental.

It will depend on clear choices about how we grow, where we invest and how we organise ourselves as a system. It will recognise tourism not just as a set of markets, but as something that shapes places, communities and livelihoods across the country

Over the past year, our focus has been on rebuilding momentum and restoring confidence. 

The work now underway is about ensuring that growth is intentional, coordinated and sustainable. 

Our next steps must be about designing a system supporting growth, protecting place, and delivering value for both visitors and New Zealander

Thank you for the opportunity to share some of these next steps with you today. I look forward to your questions and to continuing this conversation together.

** Published at approx. 5pm 26 March 2026, subject to check against delivery.

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/26/opening-remarks-otago-tourism-policy-school/

Posted on

2026 Ningbo Image Overseas Exhibition Concludes Successfully in Hong Kong, China

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 26 March 2026 – On the afternoon of 21 March, the 2026 Ningbo Image Overseas Exhibition took place at the Hong Kong CineArt MegaBox. Using visual media as a connecting thread, the event built a bridge for cultural exchange between Ningbo and Hong Kong, allowing Hong Kong audiences to experience the charm of Ningbo up close.

The event comprised three components: a Ningbo-themed film screening, a creative salon, and the ‘Experience Ningbo’ city exhibition, attracting enthusiastic participation from staff and students of Hong Kong Baptist University, as well as local cultural figures.

The Ningbo-themed film screening presented three films from Ningbo and five short films from the 30°Ningbo Short Film Festival, showcasing Ningbo’s cultural heritage and natural scenery through the lens.

The creative salon invited three guests—director Jiang Xiaoxuan, Hong Kong Baptist University lecturer Lai Kin-fung, and Southern Film Company Limited‌ Manager Lin Yunhua—to explore new avenues for the visual dissemination of local culture from the perspectives of film and television production and the cultural fusion between the two regions.

The “Experience Ningbo” exhibition, through the promotion of local cuisine and scenic beauty alongside displays of urban cultural and creative products, allowed audiences to experience Ningbo through both sight and taste. Many visitors expressed their desire to visit Ningbo in person.

This event created a “visible, tangible and portable” record of the city’s culture, further deepening cultural exchanges between Ningbo and Hong Kong. Moving forward, the film exhibition will tour more overseas cities, using the medium of film to promote Ningbo to the world.

Hashtag: #2026NingboImageOverseasExhibition

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/2026-ningbo-image-overseas-exhibition-concludes-successfully-in-hong-kong-china/

Posted on

Boao: Where the World Meets | Qionghai: Where Free Trade Thrives

Source: Media Outreach

QIONGHAI, CHINA – Media OutReach Newswire – 26 March 2026 – From March 24-27, the ” Boao: Where the World Meets, Qionghai: Where Free Trade Thrives” City Exhibition was held at Boao’s Dongyu Island Cultural Park. This marks the first major city showcase since the launch of Hainan Free Trade Port’s island-wide special customs operations—providing a panoramic window into Qionghai’s role as a core functional zone of the free trade port. Woven with the theme of global connection and open development, the exhibition turns policies and culture into immersive, sensory experiences through innovative technology and design.

The opening hall’s “Digital Twin Experience Pod” offers a glimpse into daily life in tomorrow’s Qionghai—all through the use of an identity card. The interactive “Cycle Through Qionghai” installation takes guests on a dynamic ride along the Wanquan River, through historic Nanyang hometowns—settlements built by overseas Chinese returning from Southeast Asia, and into Qionghai’s stunning coastal and mountain scenery.

A key highlight is the frontier technology from the Boao Lecheng International Medical Tourism Pilot Zone. Breakthrough innovations—including the world’s first automatic exophthalmometer, a non-invasive glucose monitor, a facial recognition system for genetic screening, and the Ruiwatch wearable—made their collective public debut, showcasing how “global medical innovations meet their first patients in China.”

As China’s only Medical Tourism Special Zone, Qionghai is not just a hub of medical “tech marvels”—it is a natural wellness destination. It brings together world-class medical devices, privileged treatment policies, and international health management systems, making “access to global cutting-edge healthcare” an everyday reality. From Lecheng’s precision medicine to seaside healing, from Traditional Chinese Medicine wellness to sports recovery, Qionghai is building an integrated ecosystem of medical care, wellness, tourism, and living.

With the Free Trade Port now in full operation, this coastal city invites health seekers worldwide to begin a journey of total renewal—where advanced medicine meets natural vitality, right here in Qionghai.

Hashtag: #CultureandTourismofGuizhouProvince #Qionghai

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/boao-where-the-world-meets-qionghai-where-free-trade-thrives/

Posted on

InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

Source: Media Outreach

BEIJING, CHINA – EQS Newswire – 26 March 2025 – InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.

2025 marked InnoCare’s 10th anniversary and a milestone year of transformative growth and strategic execution. The Company achieved its first full year profitability, secured two new drug application (NDA) approvals, enhanced market penetration of its core products, accelerated globalization, and made breakthroughs across multiple pipelines. With numerous “China First” achievements, InnoCare continues to accelerate its 2.0 development strategy, demonstrating its strong ability to translate scientific innovations into sustainable long-term growth.

Financial Highlights

  • Revenue grew 135.3% year-on-year to RMB 2,375 million[1] in 2025, mainly driven by robust commercial growth and two strategic business development (BD) deals.
  • Profit reached RMB 644 million, achieving profitability for the first time, mainly due to significant commercialization growth and global out-licensing deals.
  • Gross Profit Margin increased by 5.7 percentage points to 92%.
  • Research and Development Investment increased by 16.9% to RMB 952 million in 2025, reflecting advancements of multiple Phase III registrational trials, as well as increased investments in new technology platforms such as ADCs and molecular glue.
  • Cash and Related Accounts Balance[2] stood at approximately RMB 7.8 billion as of December 31, 2025 and achieved positive operating cash flow for the first time. This strong cash position provides InnoCare with the flexibility to expedite global clinical development of key assets and invest in new technology platforms.

Accelerating Globalization with Transformative Deals

In 2025, InnoCare accelerated the implementation of its globalization strategy, unlocking global value of its core pipeline with two out-licensing deals, further enhancing the Company’s global influence and financial performance, and marking a significant step forward in its global expansion.

On Oct. 8, InnoCare entered into a transformative licensing agreement with Zenas for its autoimmune disease pipeline, including orelabrutinib. The agreement includes up to US$100 million in upfront and near-term milestone payments, and up to 7,000,000 shares of Zenas common stock, with a total deal value exceeding US$ 2 billion, setting a new record for small molecule autoimmune out-licensing in China.

This strategic collaboration marks a significant milestone in InnoCare’s globalization journey and will leverage shared focus to accelerate the global Phase III clinical development of orelabrutinib for the treatment of primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS), maximizing its clinical and commercial value worldwide, and advance a novel oral IL-17 AA/AF inhibitor and a brain-penetrant oral TYK2 inhibitor into clinical trials.

In addition, InnoCare entered into a licensing agreement with Prolium to further its global presence in 2025. In March 2026, Prolium announced first dosing of healthy volunteers in an ongoing single ascending dose study of ICP-B02 (PRO-203) and expects to initiate a multinational Phase I/II study of ICP-B02 in systemic sclerosis (SSc) in the second quarter of 2026, with additional studies in B-cell-driven autoimmune disease expected to follow.

Dr. Jasmine Cui, the Co-founder, Chairwoman, and CEO of InnoCare, said, “Building on an inspiring decade of solid growth, we have continuously enhanced our fully integrated platform ranging from original innovation, clinical development, commercialization, manufacturing, to business development, achieving our strategic goal of break-even ahead of schedule, marking a significant milestone in our development history. As we enter our 2.0 phase of rapid development, we are focused on key strategic priorities, including securing approvals for five to six innovative drugs, advancing three to four products globally, and progressing five to ten differentiated molecules into clinical trials. We will further accelerate globalization, significantly increase revenue, and deliver more high-quality innovative therapies to benefit patients worldwide. “

Building A Leading Franchise in Hemato-Oncology

In 2025, InnoCare made significant progress toward building a leading hemato-oncology franchise, driven by advances in commercial execution, late-stage clinical development, and global expansion.

InnoCare continued to strengthen its commercial portfolio with orelabrutinib approved for first line chronic lymphocytic leukemia/small lymphocytic lymphoma (1L CLL/SLL) and successfully included in the updated National Reimbursement Drug List (NRDL), while tafasitamab became the first CD19 antibody approved for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) in China. As a result, drug sales increased by 43.4% to RMB 1,442 million in 2025.

Mesutoclax (ICP-248), the first BCL2 inhibitor granted Breakthrough Therapy Designation in China, continues to advance across multiple indications, including CLL/SLL, mantle cell lymphoma (MCL), acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS), with clinical trials ongoing in China and globally. Together, these three assets form the core of InnoCare’s hemato-oncology strategy, supporting near-term revenue growth with a pipeline of differentiated, late-stage therapies.

Orelabrutinib

Orelabrutinib serves as a backbone therapy in InnoCare’s extensive hemato-oncology pipeline. Its newly approved 1L CLL/SLL indication has been included in the NRDL and is recommended as a Class I treatment in the Chinese Society of Clinical Oncology (CSCO) Diagnosis and Treatment Guidelines for Malignant Lymphoma. With all four approved indications now covered under the NRDL, orelabrutinib offers stable annual treatment costs, benefiting more lymphoma patients.

The commercial team further strengthened execution capabilities and sharpened strategic focus, delivering strong sales performance throughout 2025. Improved market penetration and operational discipline laid a solid foundation for sustained revenue growth and long-term commercial success.

Internationally, orelabrutinib continued to expand its regulatory footprint, with approval granted for relapsed or refractory marginal zone lymphoma (R/R MZL) in Singapore and NDA submission for R/R MCL successfully completed in Australia.

Tafasitamab

In May 2025, the tafasitamab regimen received NDA approval for adult patients with R/R DLBCL, representing the first CD19 antibody therapy approved in China for this indication and a key addition to InnoCare’s commercial portfolio.

Building on the initial commercial launch in September 2025, 2026 will mark the first full year of tafasitamab sales in China. Moreover, tafasitamab has been included as a Class II recommendation in the CSCO Guidelines, which will help address unmet clinical needs in this patient population and provide meaningful benefits.

Mesutoclax (ICP-248)

As the first BCL2 inhibitor granted BTD in China, mesutoclax has rapidly advanced across multiple registrational studies. The Phase III combination regimen with orelabrutinib for 1L CLL/SLL completed patient enrollment within 10 months, demonstrating strong clinical execution. This fixed-duration combination regimen has the potential to deliver deeper remissions, bringing hope for clinical cure and representing a promising treatment option.

A registrational trial in BTK inhibitor-treated MCL is progressing rapidly, and a Phase III randomized, double-blind, multicenter study of mesutoclax in combination with orelabrutinib versus pirtobrutinib (a reversible BTK inhibitor) in r/r MCL is expected to commence in 2026.

Global development of mesutoclax in AML and MDS is progressing across China, U.S., and Australia. The global AML and MDS markets are projected to reach US$8 billion[3] and US$11 billion[4] by 2034 respectively.

Mesutoclax, as a monotherapy or in combination with orelabrutinib, demonstrated a favorable safety profile for CLL/SLL across all dose levels tested. In the CLL/SLL patients receiving mesutoclax in combination with orelabrutinib, the overall response rate (ORR) was 100%, the complete response rate (CRR) was 57.1%, and the peripheral blood uMRD rate at 36-week was 65%. The clinical data from mesutoclax monotherapy demonstrated potential best in class efficacy in MCL patients, particularly in heavily treated patients with BTK inhibitor refractory. Among MCL patients who were BTK inhibitor-refractory, the ORR was 84.0% and the CRR was 36.0%. Mesutoclax in combination with orelabrutinib demonstrated a consistently favorable safety profile across B-cell malignancies (MCL, MZL, CLL/SLL). This oral, chemo-free regimen has the potential to establish a novel therapeutic option for B-NHLs. Updated data will be presented at 2026 American Society of Clinical Oncology (ASCO) annual meeting.

The combination of mesutoclax and azacitidine demonstrated a favorable safety profile and encouraging anti-tumor activity not only in AML but also in MDS patients. Among 35 evaluable treatment-naive AML patients, the regimen achieved an 85.7% composite CR rate and an 86.7% uMRD rate, with no mortality observed with 90 days. Preliminary data among MDS patients is also promising. There were no dose-limiting toxicities (DLT) or tumor lysis syndrome (TLS) events. Detailed data to be presented at 2026 ASCO annual meeting.

Developing B-cell and T-cell Pathways in Autoimmune Diseases

Autoimmune diseases can affect almost every organ in the body and may arise at any stage of life. The global market for autoimmune disease therapeutics is anticipated to reach $185 billion by 2029[5]. The Company has fortified its powerful discovery engine on cutting-edge global targets for the development of autoimmune therapeutics through B-cell and T-cell pathways, with the aim of delivering first-in-class and/or best-in-class treatments to address the massive unmet clinical needs and strong market potential in China and globally.

Orelabrutinib

Immune Thrombocytopenia (ITP): With over 200,000 new cases globally each year, including 60,000 in China, ITP represents a significant unmet medical need. The pivotal Phase III study has been completed, and the Company expects to submit the NDA application in the first half of 2026. ITP represents an important expansion of orelabrutinib from hematologic malignancies into autoimmune hematologic diseases, unlocking its enormous commercial potential. By leveraging the BTK inhibitor’s advantage in ITP, such as decreased macrophage-mediate platelet destruction and reduced production of pathogenic autoantibodies, orelabrutinib is well positioned to become a preferred BTK inhibitor in the field of ITP.

Systemic lupus erythematosus (SLE): There are about 8 million SLE patients worldwide. Orelabrutinib is the first BTK inhibitor to demonstrate significant efficacy in a Phase II clinical trial for SLE. The Phase IIb study met its primary endpoint, and a Phase III registrational study was initiated in the first quarter of 2026. Under stringent steroid-tapering requirements, orelabrutinib 75 mg once daily (QD) achieved a statistically significant improvement in SLE Response Index-4 (SRI-4) rate compared with placebo at Week 48 (57.1% vs. 34.4%, p

Multiple Sclerosis (MS): The US SPMS and PPMS market exceeds US$12 billion[6], representing a significant commercial opportunity. Based on the deal, InnoCare has been cooperating with Zenas to accelerate two global Phase III clinical trials of orelabrutinib for the treatment of PPMS and SPMS, further unleashing its global value in autoimmune diseases.

  • Initiated Orelabrutinib PriMroSe PPMS trial, a Phase III, global registration-directed, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of orelabrutinib in patients with PPMS in the third quarter of 2025. More information on the Phase III PriMroSe trial (NCT07067463) is available at clinicaltrials.gov.
  • Orelabrutinib Monarch trial for non-active SPMS (naSPMS) is planned, a Phase III, global registration-directed, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of orelabrutinib in patients with naSPMS is expected to initiate in the first quarter of 2026. More information on the Phase III Monarch trial (NCT07299019) is available at clinicaltrials.gov.

Two TYK2 Inhibitors

The global dermatology drug market has enormous potential, with over 500 million patients suffering from dermatological diseases worldwide. By 2035, the global dermatology market size is projected to reach nearly US$100 billion. InnoCare is well positioned to capture this opportunity with two TYK2 inhibitors targeting multiple high-value indications, including atopic dermatitis (AD), psoriasis, vitiligo, nodular prurigo (PN), urticaria (CSU), cutaneous lupus erythematosus (CLE), and other dermatological diseases. The global AD market is projected to reach $30 billion[7] by 2030, the vitiligo market $3 billion[8] by 2032, the CSU market $3 billion[9] by 2029, the psoriasis market $58 billion[10] by 2032, the PN market $3 billion[11] by 2034, and CLE market US$ 7.9 billion[12] by 2032.

Soficitinib (ICP-332)

The Phase III clinical study of soficitinib in patients with moderate to severe atopic dermatitis (AD) completed patient enrollment, with data readout expected in mid-2026. The Phase II clinical study of soficitinib in patients with vitiligo has also completed patient enrollment. Additional studies in prurigo nodular, urticaria, and psoriasis are progressing rapidly. As a result, soficitinib is expected to deliver a series of clinically meaningful data catalysts in 2026.

Data from the Phase II clinical trial of soficitinib in patients with moderate-to-severe AD were published in JAMA Dermatology in January 2026. The journal concluded that soficitinib demonstrated a favorable safety profile and encouraging efficacy in patients with AD.

Soficitinib achieved multiple efficacy endpoints in the study. The percentage improvement from baseline in EASI at Week 4 were 78.2% in the soficitinib 80 mg group, 72.5% in the soficitinib 120 mg group, and 16.7% for those receiving placebo. There was a statistically significant higher EASI-75 response rate with both soficitinib doses (64.0% for each; difference vs placebo, 56.0%) than with placebo and a greater percentage of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA) score of 0 or 1 and improvement of 2 or more points at Week 4 in the soficitinib 80 mg group vs placebo (36.0%; difference vs placebo, 32.0%, P=0.005). Meanwhile, soficitinib demonstrated rapid relief of pruritus and significant improvement in quality of life. Substantial reductions in Pruritus NRS severity and frequency scores were observed on Day 2 of treatment compared to placebo, with continued improvement over time, peaking at Week 4 for both severity and frequency (all P

ICP-488

The Phase III clinical study in psoriasis has completed patient enrollment, and the Phase II trial for CLE is progressing rapidly. The IND for Sjögren’s syndrome has been submitted, and additional indications and combination strategies are under evaluation.

Data on ICP-488 for the treatment of patients with moderate-to-severe plaque psoriasis has been released at the 2025 AAD Annual Meeting as a late-breaking oral presentation. The study results demonstrated that ICP-488 is highly effective in treating psoriasis at both the 6 mg QD and 9 mg QD doses. Moreover, ICP-488 exhibited favorable safety and tolerability profiles, reinforcing its potential as a valuable treatment option for moderate-to-severe psoriasis patients.

At week 12, the percentage of patients achieving PASI 75 was significantly superior in the ICP-488 6 mg QD group (77.3%) and the 9 mg QD group (78.6%) than that of the placebo group (11.6%); the percentages of subjects achieving PASI 90 and sPGA of 0 (clear) or 1 (almost clear) were also significantly higher in the ICP-488 6 mg QD group (36.4%, 70.5%) and 9 mg QD group (50.0%, 71.4%) compared to the placebo group (0%, 9.3%).

ICP-538

The first healthy volunteer has been dosed in a clinical trial of ICP-538, a VAV1-directed molecular glue degrader (MGD), in China. This is the first VAV1 degrader approved to enter clinical trials in China. ICP-538 is a novel, potent, highly selective, orally administered molecular glue degrader targeting VAV1, a key protein downstream of T-cell and B-cell receptors. ICP-538 induces rapid and efficient degradation of the VAV1 protein in a dose-dependent manner by selectively mediating the formation of a ternary complex between the CRBN E3 ubiquitin ligase and the VAV1 protein. ICP-538 will be developed for the treatment of autoimmune diseases, such as inflammatory bowel disease, systemic lupus erythematosus, and multiple sclerosis. Currently, there are no approved VAV1-targeted therapies globally.

ICP-054

The IND application of ICP-054 (ZB021), a novel oral IL-17AA/AF inhibitor, was submitted. ICP-054 is a novel, oral, highly potent and selective IL-17AA/AF inhibitor with significant therapeutic potential in autoimmune and inflammatory diseases. ICP-054 can effectively block the signal transduction pathways of IL-17AA homodimer and IL-17AF heterodimer, thereby inhibiting the release of pro-inflammatory cytokines and chemokines, exerting an anti-inflammatory effect. Simultaneously, it reduces excessive proliferation of keratinocytes and inflammatory cell infiltration, improving skin lesions and thus suppressing the occurrence of autoimmune and inflammatory diseases.

Under the BD agreement, Zenas holds exclusive rights to develop, manufacture and commercialize the oral, IL-17AA/AF inhibitor in all territories outside Greater China and Southeast Asia.

Building Innovative Solid Tumor Assets

InnoCare has been building a robust and diversified portfolio to address significant unmet medical needs across multiple tumor types. The Company is committed to combining targeted small molecules with next-generation antibody-drug conjugates (ADCs) to maximize clinical benefit while minimizing systemic toxicity. The R&D team aims to focus on tumor types with high unmet needs, and to develop therapies that are differentiated in mechanism of action, potency, and safety profile. InnoCare’s proprietary ADC technology platform, alongside promising precision medicine candidates like zurletrectinib, positions the Company to establish a strong presence in the field of solid tumor treatment.

Zurletrectinib (ICP-723)

Zurletrectinib, a next generation TRK inhibitor, represents InnoCare’s first approved therapy in solid tumors and its third innovative product approved for marketing. Zurletrectinib is indicated for adult and adolescent patients (12–18 years) with NTRK gene fusion-positive tumors.

In the registrational clinical trial for patients with NTRK fusion-positive solid tumors, zurletrectinib demonstrated outstanding efficacy and a favorable safety profile. The study results showed an ORR of 89.1%, a disease control rate (DCR) of 96.4%, and 24-month progression-free survival (PFS) and overall survival (OS) rates of 77.4% and 90.8% respectively.

InnoCare expects to submit NDA for pediatric patients (2 years

In-House Developed Antibody-Drug Conjugate (ADC) Platform

The Company has developed a cutting-edge ADC platform with proprietary linker-payload (LP) technologies, aimed at the delivery of potent and targeted therapies for cancer treatment. This platform allows for the creation of highly differentiated ADCs with improved efficacy and safety profiles. Key features of the platform include:

  • Irreversible bioconjugation: ensuring stable antibody-linker bioconjugation for improved stability.
  • Hydrophilic linker: enhancing ADC stability and achieving a high drug-to-antibody ratio (DAR) of 8.
  • Novel payload: incorporating highly potent cytotoxic payloads with a strong bystander killing effect.

The platform is expected to deliver ADCs with strong tumor-killing efficacy and an adequate therapeutic window, thereby broadening treatment options for cancer patients and improving their clinical outcomes. As the platform continues to evolve, the Company is poised to expand its portfolio with multiple differentiated ADC candidates, further advancing precision medicine in oncology.

ICP-B794: A Novel B7-H3 Targeted ADC for Solid Tumors

InnoCare is advancing the Phase I dose escalation trial of novel B7-H3 targeted ADC, ICP-B794. ICP-B794 is a novel ADC comprising a humanized anti-B7-H3 monoclonal antibody conjugated to a potent in-house developed payload via a protease-cleavable linker. This combination ensures precise targeting of tumor cells while minimizing off-target effects, offering a promising treatment for solid tumors such as lung cancer, esophageal cancer, nasopharyngeal cancer, head and neck squamous cell carcinomas, prostate cancer, and others. ICP-B794 has demonstrated superior anti-tumor activity in animal models compared with other ADCs, and exhibited significant tumor-killing effects even in large tumors.

Early clinical observations indicate favorable pharmacokinetics and tolerability, with preliminary signs of antitumor activity, which validate the Company’s proprietary ADC platform for solid tumor development.

ICP-B208: A Novel CDH17 Targeted ADC for Solid Tumors

Building on the encouraging efficacy and safety of ICP-B794, the second ADC candidate, ICP-B208, is designed to target CDH17, a calcium-dependent cell adhesion protein that plays a key role in tumor cell proliferation, migration, and metastasis. Its tumor-restricted expression and functional role in cancer biology make CDH17 an attractive and differentiated target for ADC therapy, enabling the delivery of potent cytotoxic payloads specifically to tumor cells while minimizing systemic toxicity, which can be developed for the treatment of gastrointestinal cancers, including gastric, colorectal, pancreatic ductal adenocarcinoma, and cholangiocarcinoma. Preclinical studies show that ICP-B208 demonstrates good anti-tumor activity even in CDH17-low tumors. The IND application has been submitted in March 2026.

InnoCare plans to submit at least two more ADC INDs within 2026, further expanding its differentiated solid tumor pipeline.

To know more about the detailed financial data and business updates of InnoCare 2025 annual results, please log in to https://www.innocarepharma.com/en/investor/home .

Conference Call Information

InnoCare will host a conference call at 8:30 p.m. Beijing time on March 25 in English and at 9:00 a.m. Beijing time in Chinese on March 26, 2025. Participants must register in advance of the conference call. Details are as follows:

For English conference call, please register through the below link:
https://goldmansachs.zoom.us/webinar/register/WN_rVCbaOqMSM-QJQlfzlTEvw

For Chinese conference call, please register through the below link:
https://s.comein.cn/qz7duugd

Forward-looking Statement

This report contains the disclosure of some forward-looking statements. Except for statements of facts, all other statements can be regarded as forward-looking statements, that is, about our or our management’s intentions, plans, beliefs, or expectations that will or may occur in the future. Such statements are assumptions and estimates made by our management based on its experience and knowledge of historical trends, current conditions, expected future development and other related factors. This forward-looking statement does not guarantee future performance, and actual results, development and business decisions may not match the expectations of the forward-looking statement. Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance.

[1] The financial figures in this article are based on Hong Kong Financial Reporting Standards

[2] Include cash and bank balances, other current assets, financial assets among other non-current assets, and interest receivable

[3] Global Growth Insights

[4] Nova One Advisor, Insight Code: 8817

[5] iHealthcareAnalyst, Inc., Oct. 3, 2023

[6] Zenas estimate based on reported prevalence and current pricing of B cell therapies approved for MS

[7] Grand View Research

[8] Data Bridge Market Research

[9] The Business Research Company

[10] Fortune Business Insights

[11] Global Market Insights

[12] Data Bridge Market Research

Hashtag: #InnoCare

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/innocare-releases-2025-results-and-business-highlights-achieving-first-annual-profit/

Posted on

Zuellig Pharma Reinforces Commitment to Japan through Its New Misato Depot, Advancing Clinical Logistics and Sourcing Excellence

Source: Media Outreach

MISATO, JAPAN – Media OutReach Newswire – 26 March 2026 – Zuellig Pharma today announced the successful relocation of its new clinical depot to Misato, strengthening its ability to deliver global quality standards with local operational agility and further strengthening its clinical supply capability across Asia Pacific. Japan remains one of the region’s preferred locations for clinical research, underpinned by its strong focus on medical advancement, rigorous ethical standards and commitment to healthcare.

Medical innovation across the region continues to accelerate, with China, India, Australia, Japan, South Korea, Taiwan and Singapore emerging as key pillars of Asia Pacific’s clinical trial ecosystem over the past five years[1]. Against this backdrop, the move in Japan reinforces Zuellig Pharma’s commitment to supporting sponsors and clients with reliable, compliant and seamless access to Japan – advancing its broader mission to make healthcare more accessible.

The new depot will bring together Zuellig Pharma’s established knowledge assets, operational excellence, and clinical logistics and sourcing expertise. Backed by a highly experienced and expert-led local team, the depot delivers precision project management tailored to Japan’s intricate regulatory and logistical requirements, while enabling smoother coordination for multi-market studies as the clinical landscape continues to evolve.

“As sponsors and clients increasingly run multi-market studies, they need clinical supply partners that can deliver consistency across borders while navigating local complexity,” said John Graham, Chief Executive Officer, Zuellig Pharma. “This relocated depot will strengthen access to Japan within our regional network, helping us execute with greater reliability, compliance, and speed across the region.”

The Misato clinical depot will also provide a streamlined, turnkey solution for global sponsors seeking rapid and compliant market entry into Japan. Sponsors will benefit from the same rigorous operational excellence, regulatory adherence, and service consistency delivered by Zuellig Pharma’s strategic network of clinical depots, without the overhead of building or managing costly standalone facilities. This milestone supports Zuellig Pharma’s ongoing efforts to accelerate clinical development and improve patient access to innovative therapies across Asia Pacific.

With this strategic move, Zuellig Pharma further strengthens its position as a trusted partner for global clinical development, combining scale, expertise, and agility whilst delivering high-quality, compliant clinical logistics and sourcing solutions across Asia Pacific.

[1] https://www.clinicaltrialsarena.com/features/apac-clinical-trials-beyond-china

https://www.zuelligpharma.com/
https://www.linkedin.com/company/zuellig-pharma

Hashtag: #ZuelligPharma #ClinicalTrials #ClinicalResearch #Healthcare #Pharmaceuticals #ColdChain #Logistics

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/zuellig-pharma-reinforces-commitment-to-japan-through-its-new-misato-depot-advancing-clinical-logistics-and-sourcing-excellence/

Posted on

Contractor Confidence Rises Amid Strengthening Office Demand Across Asia Pacific

Source: Media Outreach

  • Contractor Sentiment Survey shows 70% of respondents expect improved market conditions in 2026
  • Office fit out costs diverge across the region with Japan and Taipei posting largest year-on-year increases while costs in Hong Kong held steady

HONG KONG SAR – Media OutReach Newswire – 26 March 2026 – Cushman & Wakefield’s Asia Pacific Office Fit Out Cost Guide 2026 highlights a clear shift in regional market dynamics, with sentiment strengthening and activity levels improving across several key markets. Contractor confidence has risen year-on-year, with 70% of the respondents to the firm’s annual Contractor Sentiment Survey anticipating improved conditions in 2026. This positive sentiment is further supported by the stronger‑than‑expected 92 million square feet of office absorption in 2025 and a tightening construction pipeline outside India.

Of the 180 survey respondents, nearly two thirds reported project backlogs of around six months, reflecting improving project delivery conditions across the region. While Japan and Indonesia remain outliers with longer backlogs, most markets expect stabilisation or slight improvement in delivery timelines in 2026. This alignment between contractor sentiment and strengthening occupier demand points to a more balanced and active project environment emerging across Asia Pacific.

Ranee Ng, Executive Director, Head of Project & Development Services, Hong Kong said: “As Hong Kong’s property market evolves, occupiers are seeking practical, scalable fit out strategies that deliver efficiency in high density environments. There is a clear shift toward flexible designs that can rapidly adapt to changing workforce behaviours and policy updates, while demand for sustainable materials, energy efficient construction and smart building technologies is accelerating innovation. These trends are creating a more resilient fit out ecosystem where disciplined cost management and value driven delivery allow clients to achieve compelling performance outcomes without sacrificing quality.”

Fit Out Cost Movements (YoY, 2025 → 2026)

The 2026 Guide reported a divergence in city level fit out costs (measured in USD per sq ft) across the region:

  • Costs rising: Japan and Taipei posted the largest year-on-year increases
    (Tokyo: USD 215 vs USD 195; Taipei: USD 145 vs USD 110)
  • Costs easing: Mainland China and South Korea saw declines
    (Shenzhen: USD 87 vs USD 94; Seoul: USD 130 vs USD 156)
  • Costs steady: Singapore (USD 140) and Hong Kong (USD 160) remained largely unchanged
  • Best value: India remains the region’s most cost competitive market, with most major cities ranging USD 65–73 per sq ft

These cost movements reflect evolving local construction dynamics and broader economic adjustments influencing material, labour and delivery markets across Asia Pacific.

APAC Office Market Dynamics

Even as office demand across APAC surged in 2025, Cushman & Wakefield also noted a substantial contraction in new office supply outside India. Development pipelines have moderated sharply due to rising construction costs and reduced project feasibility, intensifying competition for prime space. As supply tightens, vacancy rates in high quality buildings – particularly in core CBD locations – are expected to trend lower, reinforcing the ongoing flight to quality amongst occupiers.

Report author and Head of International Research, APAC & EMEA, Dr. Dominic Brown said: “After a resilient 2025, the Asia Pacific office market is now transitioning into a more stable phase, supported by a gradual return of business confidence. Coupled with the tightening supply pipeline outside India, which is reshaping the competitive landscape for high quality space, these collective shifts indicate a meaningful turning point for the region in 2026, with both occupiers and investors positioned for renewed momentum.”

Notes:

  1. Data and pricing benchmarks in the guide reflect market conditions as of December 2025. For insights on the Middle East conflict, please refer to Cushman & Wakefield’s Middle East Conflict: Implications for Energy, Inflation, and CRE.
  2. Cushman & Wakefield publishes Office Fit Out Cost Guides for APAC, EMEA and the Americas, which are all available [here].

Hashtag: #CushmanWakefield

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/contractor-confidence-rises-amid-strengthening-office-demand-across-asia-pacific/

Posted on

DITP Hosts Thai Night Hong Kong 2026 to Strengthen Thailand’s Entertainment Industry Networks with Global Partners

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 25 March 2026 – The Department of International Trade Promotion (DITP), Ministry of Commerce, successfully hosted “Thai Night Hong Kong 2026” on 18 March 2026 at the Ballroom, JW Marriott Hong Kong, Hong Kong Special Administrative Region of the People’s Republic of China. The event aimed to foster business networking and promote collaboration between Thai entrepreneurs and international partners in the film and entertainment industry, with over 517 participants from across the global entertainment sector, including investors, content creators, and media representatives.

The event was graciously presided over by Her Royal Highness Princess Ubolratana Rajakanya Sirivadhana Barnavadi, who continues to play a vital role in supporting and promoting Thailand’s film and entertainment industry on the global stage. The occasion also provided a valuable platform for Thai entrepreneurs to expand business opportunities and strengthen international partnerships.

Thai Night Hong Kong 2026 was held alongside the Hong Kong International Film & TV Market (FILMART) 2026, one of Asia’s leading marketplaces for film and television content. The event served as a platform to celebrate the achievements of Thailand’s entertainment industry while showcasing the capabilities of Thai content creators to global buyers, investors, and industry stakeholders.

This year’s event was presented under the theme “Reimagining Thailand”, highlighting Thailand as a comprehensive creative destination for film and entertainment production. The concept reflects the country’s strengths in skilled talent, diverse filming locations, internationally recognized production standards, and advanced post-production capabilities.

The atmosphere of the event was vibrant and dynamic, with participants from various countries engaging in discussions, exchanging insights, and exploring opportunities for co-production and investment within Thailand’s entertainment sector.

In addition, the event featured live performances by Thai entertainment industry players, demonstrating the creativity and production excellence of Thai content. These performances blended contemporary storytelling with cultural identity, leaving a strong impression on international attendees and reinforcing Thailand’s position as a compelling creative partner on the global stage.

The successful organization of Thai Night Hong Kong 2026 reflects growing international interest in Thailand’s entertainment industry and underscores its potential as a key player in the global content landscape. The event also served as an important platform for Thai entrepreneurs to expand their market reach and build sustainable partnerships with international stakeholders.

Hashtag: #DITP

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/25/ditp-hosts-thai-night-hong-kong-2026-to-strengthen-thailands-entertainment-industry-networks-with-global-partners/

Posted on

SenseTime Group Reports Record High Revenue of Over RMB 5 billion in 2025; Second Half EBITDA Turns Positive

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 25 March 2026 – SenseTime (the “Company”; Stock Code: 0020) announced its annual results for 2025. For the full year, total revenue rose 33% year-on-year to more than RMB 5 billion, reaching a new record high and marking the fastest growth in three years. Net loss narrowed by 58.6% year-on-year, while adjusted net loss declined for a fourth consecutive half‑year period, with the pace of year‑on‑year reduction accelerating. EBITDA for the second half of 2025 reached RMB 380 million, turning positive for the first time since listing.

The Company has successfully transitioned from a technological investment phase into a period of sustainable and accelerated growth. During the reporting period, its endogenous growth momentum continued to strengthen, alongside improved capital efficiency and resilient cash flow generation. Trade receivables collection rose to a record RMB 4.87 billion. Operating cash flow recorded a positive net inflow in the second half of 2025, marking the first such achievement since listing.

Looking ahead, the Company plans to launch a new foundational model based on its second-generation NEO architecture in the second quarter of this year. The model is expected to deliver a further step in efficiency and cost-effectiveness, enabling the broad deployment of agentic AI applications.

Dr. Xu Li, Chairman of the Board and Chief Executive Officer of SenseTime, said: “We firmly believe that the deep integration of language and vision represents the most effective path to pushing the boundaries of artificial intelligence. Built on our innovative NEO architecture, we have achieved unified understanding and generation, while exploring a new ‘Scaling Law’ for multimodal intelligence. These technological breakthroughs, together with the deep integration of agentic AI, will unlock new application possibilities and enable a new generation of vertical use cases. While continuing to drive innovation in core technologies, SenseTime has delivered dual growth in both revenue and EBITDA, demonstrating strong growth resilience and operational efficiency across the industry, and is steadily advancing towards high-quality development.”

Continuously rolling out native multimodal large models, “efficiency enhancement + cost reduction” drives accelerated commercial growth

In 2025, SenseTime continued to invest in cutting-edge R&D, delivering breakthrough progress across large-model architecture innovation, training paradigms, inference efficiency, and spatial understanding, while maintaining its leading position in China.

The performance of the SenseNova multimodal large model continues to improve steadily, maintaining long-term leadership across multiple authoritative benchmarks. The Company has successively released and open-sourced the SenseNova-SI Spatial Intelligence Model. In a comprehensive evaluation incorporating several internationally recognized spatial intelligence benchmarks, SenseNova-SI delivered outstanding results, ranking first globally among peer models. In parallel, the open-source Kairos-SenseNova became the first embodied native world model to achieve integrated multimodal understanding, generation, and prediction. In December 2025, SenseTime also unveiled and open-sourced NEO, an fundamentally new native multimodal model architecture. NEO achieves state-of-the-art performance comparable to industry peers of a similar scale while requiring only one-tenth of the training data and computing power. Together, these breakthroughs redefined model training paradigms and inference efficiency, marking SenseTime’s entry into a new phase in its pursuit of deep multimodal integration

Leveraging the leading capabilities of its SenseNova multimodal large model, SenseTime has established a robust, scalable and replicable B2B business model. By applying a comprehensive framework that assesses task complexity and fault tolerance, the Company is able to unlock the closed-loop value of AI agents across strategic use cases, including office productivity, finance, marketing, and content generation. Its customer base spans a broad range of industries, encompassing automotive, smart devices, consumer goods, Internet services, embodied intelligence, financial services, education and healthcare.

Meanwhile, SenseTime has continued to make progress in developing a new generation of AI-native consumer applications. The Kapi product series has successfully built a user base numbering in the tens of millions, underscoring the strong growth potential of AI-native applications and demonstrating the Company’s ability to embed advanced AI technologies into everyday life.

SenseCore: Deeper coordination between computing infrastructure and model R&D unlocks international commercial potential

As the core technological pillar of its “Infrastructure – Model – Application” strategy, SenseCore achieved a significant transition in 2025, converting technological strengths to a fully developed industrial closed loop. During the year, it supported nearly one million model R&D tasks, effectively unlocking the full chain from underlying hardware to top-level applications, and from software stacks to model adaptation. Notably, the LightX2V World Model Inference System delivered breakthrough performance on domestic hardware, outperforming leading overseas chips.

SenseCore accelerated collaboration across China’s domestic technology ecosystem, positioning itself as a key chain master within industry. It partnered with more than a dozen chip makers, including Huawei Ascend, Hygon and Cambricon, to launch the SenseCore Computing Power Mall. SenseCore has since become a core partner of leading research institutes, Internet giants, pan-entertainment groups, embodied-intelligence robotics firms and large-model unicorns, and has also launched China’s first overseas Chinese-led computing cluster in Saudi Arabia.

As of the release of this result announcement, the total operational computing scale of SenseCore had reached 40,400 PetaFLOPS (FP16).

CV 2.0 records first‑ever net profit and positive cash flow; “X” Businesses gains strong recognition from external investors

SenseTime’s Computer Vision (CV; Visual AI) business is transitioning from a technology investment phase into a period of large-scale commercial returns. During the reporting period, CV 2.0 achieved profitability for the first time and generated positive cash flow for a second consecutive year, emerging as a key driver of the Company’s revenue growth and cash-flow improvement. SenseTime has maintained the leading position in China’s CV market for nine consecutive years. Internationally, clients across Southeast Asia, Northeast Asia and the Middle East continued to repurchase CV products and services, while interest increased from clients in South America, Europe and other regions, forming a replicable, scalable “Chinnovation” model for global expansion.

In 2025, SenseTime firmly advanced its “1+X” strategy, establishing a highly efficient collaborative system in which the core platform (the Company) provides foundational capabilities, while ecosystem partners compete and scale within targeted verticals. This marked a strategic shift from standalone business expansion towards the multiplication of ecosystem-wide value. Ecosystem enterprises incubated by SenseTime made steady progress in financing during the year, attracting strong interest from external investors including Internet giants, leading venture capital firms and industrial funds. Notably, the edge AI chip and intelligent driving business successfully completed financing rounds and were subsequently spun off to operate independently.

Looking ahead to 2026, the Company believes it is well positioned to compete in the critical phase of the global AI industry. It will continue to deepen its native multimodal architecture, reinforcing its global leadership in the integration of native multimodal large models and spatial intelligence. Meanwhile, the Company plans to capitalize on opportunities in the merging agentic AI market, targeting rapid growth in both user scale and commercial value. The Company will also accelerate the adaptation of domestic Chinese chips, further reduce large-model inference costs, and enhance product competitiveness through superior cost-performance. Within its Visual AI business, it will leverage both domestic and international growth engines to drive large-scale expansion and establish a global benchmark for intelligent industries. In parallel, the Company will continue to advance its “1+X” strategy to capture incremental returns arising from the accelerating intelligent transformation of vertical industries.

Hashtag: #SenseTimeGroup

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/25/sensetime-group-reports-record-high-revenue-of-over-rmb-5-billion-in-2025-second-half-ebitda-turns-positive/

Posted on

Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes

Source: Media Outreach

  • UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk
  • In a phase 2 trial in Chinese people with type 2 diabetes, UBT251 showed a mean HbA1c reduction of up to 2.16%, and a mean body weight reduction of up to 9.8% after 24 weeks, showing improvements relative to placebo and semaglutide 1 mg
  • The safety and tolerability profile of UBT251 appeared consistent with what has been observed in other clinical trials with triple-G agonists.

GAUNG DONG, CHINA and BAGSVÆRD, DENMARK – Media OutReach Newswire – 25 March 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G).

UBT251 is being jointly developed by TUL’s wholly-owned subsidiary, The United Bio-Technology (Hengqin) Co., Ltd. (United Biotechnology) and Novo Nordisk under an agreement signed in March 2025. United Biotechnology is responsible for development in Chinese mainland, Hong Kong, Macau and Taiwan, while Novo Nordisk is responsible for development in the rest of the world.

The trial, conducted by United Biotechnology, investigated the safety and efficacy of once-weekly injectable 2 mg, 4 mg and 6 mg doses of UBT251 compared to placebo and semaglutide 1 mg in Chinese people with type 2 diabetes. From a baseline mean glycated haemoglobin (HbA1c) of 8.12%, the highest mean HbA1c reduction observed for people treated with UBT251 was 2.16% compared to 1.77% for the semaglutide 1 mg group and 0.66% for the placebo group after 24 weeks of treatment.

From a baseline mean body weight of 80.1 kg and a mean BMI of 29.1 kg/m², the mean body weight reduction in the UBT251 groups was up to 9.8% compared with 4.8% in the semaglutide 1 mg group and 1.4% in the placebo group1.

Moreover, UBT251 showed improvements relative to placebo on key secondary endpoints, including waist circumference, blood pressure and lipids. The safety and tolerability profile of UBT251 appeared consistent with what has been observed in other clinical trials with triple-G agonists.

“The success of the phase 2 trial for UBT251 in Chinese patients with type 2 diabetes marks a significant milestone in the innovative development of TUL,” remarked Mr Tsoi Hoi Shan, Chairman of TUL. “We will fully advance the phase 3 trial in China, committed to providing superior treatment options for patients worldwide.”

“Following the recent positive read-out of phase 2 data in people with overweight or obesity, we are encouraged to see the results of this trial, which also demonstrate the potential of UBT251 in a type 2 diabetes population,” said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk. “Novo Nordisk will initiate a global phase 2 trial with UBT251 in people with type 2 diabetes later this year, and we are already conducting a global phase 2 trial in weight management that will read out next year.”

Novo Nordisk’s recently initiated global phase 1b/2a trial is investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of different doses of UBT251 for up to 28 weeks in around 330 people living with overweight or obesity. Topline data from that trial is expected in 2027. Novo Nordisk expects to initiate the global phase 2 trial with UBT251 in people with type 2 diabetes in the second half of 2026.

United Biotechnology will present detailed data from the Chinese phase 2 trial at a medical congress later this year. Based on the results of this trial, the company is planning to initiate two phase 3 trials in Chinese patients with type 2 diabetes.

About the Chinese phase 2 trial

This randomised, double-blind, placebo- and semaglutide-controlled trial enrolled a total of 211 Chinese patients with type 2 diabetes (managed with lifestyle intervention alone or in combination with metformin). At baseline, the patients had a mean HbA1c of 8.12%, a mean body weight of 80.1 kg, and a mean body mass index (BMI) of 29.1 kg/m².

Patients were randomly assigned to receive weekly subcutaneous injections of UBT251 in doses of 2 mg, 4 mg, 6 mg or placebo, or semaglutide 1 mg for 24 weeks. The primary endpoint of the trial was the change in HbA1c from baseline after 24 weeks of treatment.

About UBT251

UBT251 is a long-acting synthetic peptide triple agonist targeting the receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon.

In March 2025, United Biotechnology entered an exclusive license agreement with Novo Nordisk A/S for UBT251. Under the agreement, Novo Nordisk obtained exclusive worldwide rights (excluding Chinese mainland, Hong Kong, Macau, and Taiwan) to develop, manufacture and commercialise UBT251. United Biotechnology retained the rights for UBT251 in Chinese mainland, Hong Kong, Macau and Taiwan.

1 Estimated based on the analysis of covariance (ANCOVA) model; Based on the efficacy estimand according to the trial protocol, regardless of dose modification or changes to background metformin dose

Hashtag: #UBT251

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/25/triple-agonist-ubt251-showed-a-mean-hba1c-reduction-of-up-to-2-16-after-24-weeks-in-phase-2-trial-in-chinese-patients-with-type-2-diabetes/

Posted on

Comprehensive Support for International Students to Bolster Hong Kong’s Talent Attraction and Retention

Source: Media Outreach

ManpowerGroup Greater China and Beacon Group Partner with FGA Trust and Payment Asia to Launch “Talent in HK” Program

HONG KONG SAR – Media OutReach Newswire – 25 March 2026 – ManpowerGroup Greater China Limited (Stock Code: 2180.HK), a leading global workforce solutions provider, and Beacon Group (parent company BExcellent Group Holdings Limited, listed on the Main Board of the HKEX, Stock Code: 1775.HK), a renowned Hong Kong educational institution, today announced the joint launch of the “Talent in HK” Youth and Family Life Service Security Program.

From left to right: Ms. Lancy Chui, Senior Vice President of ManpowerGroup Greater China; Ms. June Leung, Founder of Beacon Group; Ms. Helen Chen, Chief Strategy Officer of FGA Trust

This forward-looking initiative is supported by Payment Asia, a leading payment platform in Hong Kong, providing streamlined payment channels. FGA Trust will serve as the third-party custodian. The program aims to establish an institutionalized, transparent, and collaborative ecosystem, providing end-to-end protection from education and academic support to life services and career consultancy, while injecting long-term momentum into Hong Kong’s strategy to attract and retain international talent.

As Hong Kong continues to attract top-tier students globally, many non-local students face challenges adapting to a new cultural environment upon arrival. Recently, there has been a rising trend in crimes targeting this demographic, including scams involving impersonation of government or academic institutions, as well as telecommunications and online fraud. These incidents pose substantial threats to talents’ personal and financial security, causing significant concern for their families.

In response to these social concerns and to reinforce the comprehensive security net for international students, ManpowerGroup, Beacon Group, and FGA Trust have initiated this program to provide stable, orderly support and ensure the long-term residency of talent in Hong Kong.

Holistic Talent Services: Strengthening Hong Kong’s Foundation as an International Hub

The “Talent in HK” program offers comprehensive life services for students and their families. Beacon Group will provide a long-term study plan spanning three to five years, including customized education, admissions services, profile enhancement, and application support. Simultaneously, ManpowerGroup will facilitate internships, visa arrangements, and long-term career development services.

Once a student receives an admission offer, parents can inject tuition and living expenses through Payment Asia’s official channels into a dedicated project account monitored by FGA Trust. This ensures financial security and the precise disbursement of funds. The entire process will be followed by an audit report, ensuring a smooth transition from campus to the workplace. The program’s website is expected to go live around mid-April this year, with official applications opening in May.

In an era of intensifying global competition for higher education and talent, Hong Kong remains a pivotal international financial and educational hub. Non-local students are not only a vital component of the education system but also a driving force for cross-cultural exchange and future professional talent. They are estimated to contribute over HK$10 billion in tuition fees annually, serving as a significant pillar of the local economy.

Multi-Party Collaboration: A New Paradigm for Talent Services

The core strength of the program lies in its innovative collaborative model, bringing together industry leaders:

  • ManpowerGroup Greater China (2180.HK): As the exclusive career development partner of the project, ManpowerGroup will leverage its extensive network and expertise to provide career planning, internship matching, and employment guidance, bridging the gap between graduation and professional life, and help students to have a smooth transition from academies to careers.
  • Beacon Group (parent company BExcellent Group Holdings Limited 1775.HK): As one of the initiators of the project with 37 years of experience in the education sector, Beacon Group will provide personalized academic consulting and profile enhancement, provide better guidance and adaptation for candidates to pursuit their study in Hong Kong. Its deep roots in the education sector help families navigate educational choices and avoid scams or unnecessary hurdles.
  • FGA Trust (TCSP license: TC008341): As the structural architect and asset trustee, FGA Trust will establish a specialized trust framework with individual sub-accounts for each student. This ensures funds for tuition, housing, and living expenses are managed with clear traceability, mitigating risks of fraud or improper spending.
  • Payment Asia: As the primary channel partner, Payment Asia provides secure and compliant collection channels, ensuring the seamless transfer of funds into the program’s dedicated accounts.

Long-Term Vision: Supporting Urban Competitiveness

Studying abroad is the starting point for talent development in Hong Kong. Proactive financial arrangements reduce uncertainty during status transitions and life settlement, increasing the willingness of talent to remain in the city long-term. Data suggests that initiatives like the Top Talent Pass Scheme (TTPS) continue to drive local consumption, with rents for small-to-medium residential units expected to rise by 5% this year.

Ms. Lancy Chui, Senior Vice President of ManpowerGroup Greater China, stated: “We understand the strong desire of non-local graduates to work in Hong Kong. By providing proactive career planning and internship arrangements, we can reduce uncertainty during their transition into the local workforce, helping them settle and contribute to Hong Kong’s market.”

Ms. June Leung, Founder of Beacon Group, noted: “Talent cultivation requires long-term education. We are delighted to initiate this program, integrating academic support with life security and career development to provide a comprehensive, forward-looking environment for talent growth.”

Ms. Helen Chen, Chief Strategy Officer of FGA Trust, added: “Protecting the financial security and well-being of international students is both a social responsibility and a key to consolidating Hong Kong’s status as an international education hub. This program ensures a seamless transition from study to employment, transforming international talent into a long-term driver for Hong Kong’s development.”

The launch of “Talent in HK” marks a significant step from fragmented support to a comprehensive ecosystem. Through institutional innovation and cross-sector collaboration, the program aims to provide a safe harbor for international students and their families, contributing to Hong Kong’s goal of becoming a global talent hub.

https://www.linkedin.com/company/fga-trust/

Hashtag: #FGA #Trust #Talent #Career

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/25/comprehensive-support-for-international-students-to-bolster-hong-kongs-talent-attraction-and-retention/

Posted on

HKSTP Celebrates GreenTech Hub’s First Anniversary: Public-Private Partner Network Reaches 20 Across Hong Kong

Source: Media Outreach

Driving “Attract In” and “Go Global”, Accelerating Hong Kong’s Greentech Ecosystem Development

HONG KONG SAR – Media OutReach Newswire – 24 March 2026 – Hong Kong Science and Technology Parks Corporation (HKSTP) today hosted the “Green is Action: GreenTech Hub 1st Anniversary Showcase” at InnoCentre in Kowloon Tong, highlighting the achievements of Hong Kong’s leading hub for green innovation over the past year.

HKSTP held the “Green is Action: GreenTech Hub 1st Anniversary Showcase”, Professor Sun Dong, Secretary for Innovation, Technology and Industry, (middle, front row), Dr Sunny Chai Chairman of HKSTP (5th from Left), and Mr Terry Wong, CEO of HKST (5th from right), together with GreenTech Hub partners attended the celebration ceremony to mark the first anniversary of GreenTech Hub.

In its first year, GreenTech Hub expanded its partner network from 16 to 20 public-private organisations. By facilitating 360 business matching and hosting more than 100 greentech themed events, the GreenTech Hub is injecting new momentum into Hong Kong’s development as an international green technology and green finance centre.

The celebration ceremony for the 1st Anniversary Showcase was officiated by Professor Sun Dong, Secretary for Innovation, Technology and Industry, he said: “The anniversary of GreenTech Hub today is just the beginning. In collaboration with our three major I&T parks, the Government will continue to invest in I&T infrastructure and foster the development of strategic industries, with a view to enhancing the overall I&T ecosystem and promoting interactive development of the upstream, midstream and downstream sectors.”

Dr Sunny Chai, Chairman of HKSTP, remarked, “The first anniversary of GreenTech Hub proves that Hong Kong is where global green innovation converges and scales. We have attracted world-class R&D to the city while enabling homegrown greentech to be deployed worldwide for sustainable development. Through strategic partnerships, HKSTP is forging closer connections between research, industry, capital and real-world application scenarios, accelerating commercialisation and strengthening Hong Kong’s development into an international green technology and green finance hub.”

Leveraging Hong Kong’s Role as a Super-Connector to Bridge the Full Value Chain from R&D to Commercialisation

HKSTP announced the addition of four new partners to GreenTech Hub: CLP Holdings Limited, CTF Services Limited, Invest Hong Kong, and The Hong Kong and China Gas Company Limited, further strengthening Hong Kong’s green technology collaboration network. The GreenTech Hub brings together 20 partners spanning private enterprises, public bodies, universities, and industry associations. This collaborative ecosystem facilitates business opportunities, fosters knowledge exchange and best practices, and bridges financing gaps to expedite green technology development. Furthermore, leading local universities within the partner network offer talent training, testing facilities, and application scenarios for greentech solutions, speeding the journey from R&D to commercial impact.

HKSTP’s greentech ecosystem encompasses over 230 greentech companies, spanning new energy, green building, smart city solutions and green fintech. As the city’s leading collaborative platform for green innovation in the city, GreenTech Hub works closely with its partners to provide comprehensive support for park companies, fast-track the real-world application of green solutions, and further drive the synergistic development of green technology and green finance.

Global Expert Perspectives on Green Trends Alongside a Showcase of Breakthrough Technologies

The event featured a keynote address by Mr. Ethan N. Elkind, Director of the Climate Program at the Center for Law, Energy and the Environment (CLEE) at the University of California, Berkeley School of Law, who shared insights on global green development trends. Representatives from GreenTech Hub partners and park companies also shared their insights during two thematic panel sessions focusing on ecosystem collaboration and global expansion strategies.

To further elevate Hong Kong’s international profile and thought leadership in green technology, HKSTP plans to publish its first-ever research paper focusing on Hong Kong’s greentech ecosystem and energy storage technology in the fourth quarter of this year. GreenTech covers a broad range of areas, including new energy, energy storage and carbon trading, with battery and energy storage technology identified as one of our key focus areas. Given the strong growth potential of this sector, a dedicated research study would provide a more comprehensive review of the industry landscape and help identify the critical success factors needed to accelerate the commercialisation of battery and energy storage technologies.

As a two-way platform, GreenTech Hub has successfully attracted non-local greentech companies to establish a presence in Hong Kong while supporting local greentech ventures in expanding into international markets. Featured breakthrough technology solutions included:

Aurabeat — Award-winning energy-saving sonic air purification technology

Aurabeat has developed EcoSonic, a sonic air filtration technology combining AG+ silver-ion coating with sonic emitters, designed specifically for the commercial and industrial HVAC market. Its patented technology can reduce filter pressure drop by up to 70%, save up to 50% in energy, and improve indoor air quality. The solution has already been deployed in projects including the MTR, Hysan and Marina Bay Financial Centre in Singapore, demonstrating the strength of Hong Kong greentech in overseas markets.

Gotion High-tech — Globally leading new energy solutions

Gotion High-Tech is a world-leading provider of new energy batteries and green energy solutions. Its smart mobile energy storage charging unit, equipped with 209kWh large-capacity energy storage and 150kW high-power fast charging capability, supports a wide range of new energy transport and application scenarios, offering a breakthrough solution for EV charging infrastructure.

Harmony SkyTech — Drone systems, services and industrial application solutions

Harmony SkyTech showcased an electric vertical take-off and landing fixed-wing drone and related application solutions. These can be widely deployed in scenarios including power grid inspection, oil and gas pipeline inspection, surveying and mapping, logistics, and the transport of critical supplies, underscoring the immense potential of green low-altitude technologies.

Lihe Technology — Fully automated AI-powered water quality monitoring backed by national-level R&D

Lihe Technology specialises in environmental monitoring, water management and industrial automation. Its fully automated AI water quality monitoring system enables smart, highly efficient and precise monitoring. Through strategic collaboration with a GreenTech Hub partner, the company has established Hong Kong’s first branch of a National Engineering Research Centre of Advanced Technology and Equipment for Water Environmental Pollution Monitoring — Marine Eco-Tech Innovation Centre, driving the application and development of related technologies in Hong Kong.

One Energy — Electric motorcycles and the world’s first water-cooled fast-charging battery system

One Energy provides a one-stop e-mobility solution covering electric motorcycles, smart battery swapping stations and battery management systems. Its technology effectively shortens energy replenishment time, improves safety and enhances operational efficiency. The company has successfully expanded its footprint into Southeast Asia, Europe and Africa.

Hashtag: #HKSTP

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/25/hkstp-celebrates-greentech-hubs-first-anniversary-public-private-partner-network-reaches-20-across-hong-kong/

Posted on

Mannings Introduces City-Wide Immersive Wellness Pop-Up “Mannings BoostUP – Your Wellness & Beauty Fiesta” Debuts This April in West Kowloon Cultural District

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 24 March 2026 – In a fast‑paced city where pressure and information overload are part of daily life, the definition of health has expanded beyond the absence of illness. For many Hongkongers, health now encompasses sleep quality, emotional balance, appearance confidence, and a sense of connection with others – for a more holistic, lifestyle‑driven state of wellbeing. It is highly individual, yet strengthened through community support.

This April, Mannings is teaming up with Charlz Ng, a Hong Kong–based wellness advocate, brand strategist, and community builder, to bring Wellness from concept to everyday practice through the Mannings BoostUP Fiesta. The wellness & beauty discovery playground pop up will take place on 25–26 April at the West Kowloon Cultural District. Designed as a “Wellness Buffet”, Mannings BoostUP blends interactive experiences, mind‑body sessions, community‑driven activities, and a range of complimentary health assessments from the Mannings Professional Health Team. The goal is simple but transformative: to inspire everyone to move beyond reactive health habits and discover their own version of a good state at their own pace, in their own way.

Mannings Redefines Wellness Elevating Everyday Wellbeing

As Hong Kong’s leading Health & Beauty retailer with deep roots in the city for over 50 years, Mannings has accompanied generations of customers with authentic products, trusted advice and caring service. In recent years, the Mannings brand has evolved into The Trusted Advisor for Wellness, reflecting a growing public desire for more complete and balanced approach to wellbeing – not just physically, but emotionally, socially, and in everyday confidence. For younger generations in particular, they are looking for wellness that feels fun, relatable and part of real life.

That’s why Mannings is stepping outside the store and into the community, creating fresh, lively and varied wellness experiences that are easy to join and enjoyable for all. Through Mannings BoostUP, we are bringing together local wellness experts, movement leaders, and diverse communities to reimagine what Wellness can look and feel like, turning it into a “Wellness Buffet” where everyone can explore and try something new, elevating their holistic wellbeing. From young people to families to anyone curious about feeling better, Mannings BoostUp aims to spark a more vibrant, connected wellness culture across the city.

Alex Liu, Managing Director of Mannings Hong Kong, Macau and China, said: “Today’s customers see health as much more than ‘pills when you’re ill’. They aspire to build a richer, more vibrant life for themselves, nurturing their physical, emotional, appearance and social wellbeing every day. As Hong Kong’s Trusted Advisor for Wellness, Mannings is committed to supporting our customers on this journey – through professional expertise, technology and community networks. Mannings BoostUP marks an important milestone in how we re-imagine wellness and embodies our commitment to grow together with the city.”

Doreen Cheng, Marketing Director for DFI Retail Group Health & Beauty, North Asia, and H&B Own Brand Power Brand added: “Our customers are increasingly embracing wellness as a holistic, lifestyle‑driven pursuit. Mannings BoostUP is an experiential platform where wellness becomes immersive, uplifting and part of everyday life. Through these experiences, we invite customers to reconnect meaningfully with their complete selves, so that everyone can explore their own version of ‘being in good state’, at their own pace.”

Charlz Ng, Hong Kong–based wellness advocate, brand strategist, community builder and Founder of 120 Collective shared: “At Mannings BoostUP, you don’t need to be an athlete or gym enthusiast. We aren’t chasing records or keeping score, we’re here to help people understand themselves a little better. That’s why partnering with Mannings felt natural to us. We share the belief that wellness should be part of daily life, and that everyone should be able to engage with it in their own way. It’s about the courage to try something new, the joy of discovery, and the magic that happens when we move together.”

Six-zone Playground with 40+ Immersive Experiences – One Ticket, Access to Everything

The two‑day festival brings together over 50 wellness experts, movement leaders and community builders, offering 40+ experiences across six curated zones. Whether you’re a seasoned athlete or simply health‑curious, the Fiesta is designed for absolutely everyone – it’s fun, accessible, social and endlessly explorable.

  1. Mannings House: Mannings understands that everyone’s wellness journey is different, which is why the Mannings House sits as the starting point, an inviting space where guests can ease into their experience by getting to know their own mind-body condition. The Mannings Professional Health Team will offer a range of complimentary wellness assessments, including the Health Pod, Skin Assessment, AI Hair & Scalp Assessment, Modern Chinese Medicine Consultation, Cardiovascular & Stress Monitor, and Body Composition Analysis. With personalised insights based on ndividual results, participants can quickly understand their wellness needs and navigate the rest of the themed zones with clarity – helping them discover their own wellness track towards holistic health.
  2. BoostUP Stage: Get ready for countless unexpected collaborations on the BoostUP Stage! From Cantopop to classical music, high-energy workouts to mindfulness breathing, and coffee to matcha – there are untold paths toward wellness waiting to be encountered. The BoostUP Stage is primed to deliver an unprecedented sensory experience for every participant.
  3. Bloom Garden: Offers a variety of experiences to rejuvenate body and mind. From pilates to sound healing and aroma workshops, the garden leads visitors to rediscover passion and curiosity, through holistic experiences that relax mind, body and spirit, bringing a deeper understanding of individual preferences, opening new goals for inner and outer well-being, on the journey towards being your best self.
  4. Wellness Village: A curated marketplace offering an array of innovative wellness and beauty products, including brands: Mannings Guardian, 50 Megumi, Abbott, Colgate, Dermacept, DR. ALTHEA, FATION, FineNutri, G-NiiB, lilyeve, narka, REAL BARRIER, SHIMBI METHOD and TORRIDEN. Participants explore the latest health trends and experience comprehensive nourishment and rejuvenation, inside-out and outside-in.
  5. Play Zone: Where friendly competition meets pure fun. Team challenges, playful games, and moments of laughter, because wellness is a natural state and humans naturally like to play.
  6. Breathing Corner: A quiet corner to pause and reset. No instructions, no schedule. Just space to breathe, rest, and be.

Community × Citywide Celebration: A Wellness Festival Made for Hong Kong

The Mannings BoostUP is more than an event, it’s a citywide celebration inviting Hong Kong people to reconnect with themselves and with one another. Set against our magnificent harbour on the stylish West Kowloon Cultural District, Mannings BoostUP blends movement, music, recovery and restorative stillness, encouraging everyone to step back from the rush and touch the earth again. By bringing together diverse wellness communities, the event aims to spark conversation, connection, and insight – bringing Wellness back into neighbourhoods and city lifestyles, making it feel accessible, personal, and the natural way forward.

Mannings BoostUP Fiesta – Event Details
Date: 25–26 April 2026 (Saturday + Sunday), 9:00am – 7:00pm
Venue: Great Lawn, West Kowloon Cultural District, Tsim Sha Tsui

Programme Highlights: Six themed zones, two stages, 40+ experiences, star‑coach classes, Play Zone movement challenges, mind‑body recovery workshops, wellness expert talks, and more. (* Some sessions have limited capacity and will be available on a first‑come, first‑served basis.)

Early-Bird Tickets: HK$100 (1‑day pass), HK$180 (2‑day pass)
Standard Tickets: HK$200 (1‑day pass), HK$360 (2‑day pass)
On-Site Tickets: HK$300 (1-day pass)
Ticket Sales: On sale now. Early‑bird offer available until 15 April 2026
Ticket Link: https://manningsboostup.com/

Hashtag: #Mannings #TrustedAdvisorForWellness #HealthandBeauty #ManningsBoostUP #ReimagineWellnessTogether #WellnessAndBeautyFiesta #DFIRetailGroup

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/24/mannings-introduces-city-wide-immersive-wellness-pop-up-mannings-boostup-your-wellness-beauty-fiesta-debuts-this-april-in-west-kowloon-cultural-district/

Posted on

Connecting the World, Driving Apex Growth: Apexmind Summit 2026 Successfully Held in HongKong

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 24 March 2026 – The Apexmind Summit 2026 was grandly held in Hong Kong today. The summit brought together leading global strategists, scholars, and business and policy leaders to engage in high-level dialog on how strategic opportunities are reshaping the competitive landscape. During the event, the Apexmind Consulting Hong Kong Office Inauguration was officially announced, and Founder & Chairman, Apexmind Consulting, Mr. Yao Rongjun was honored as an Honorary Fellow of the Institute of Management Consultants Hong Kong (IMCHK). These dual milestones mark that the Chinese strategic consulting force, represented by Apexmind, is actively achieving a “cultural handshake” with global business through Hong Kong. Under the vision of “Strategic Co-evolution”, it advances the global expansion in a meaningful and tangible way.

Official Launch of Apexmind Consulting Hong Kong Office

Redefining the Logic of Competition and Interpreting the Essence of Strategy in the New Era

Mr. Yao, Founder & Chairman of Apexmind Consulting, delivered a keynote, offering a profound analysis of how competitive dynamics are evolving in the new era. He emphasized: “Competition is not about meeting demand, but about winning the mind. The purpose of business is not to create customers, but to occupy a position in the mind. Business is not about improving efficiency, but about winning people’s hearts. Decisions should not be made from the inside out, but from the outside in. Strategy is not the sum of parts, but an integrated system.” In his view, as Chinese enterprises transition from product globalization to brand and model globalization, the global market urgently requires a strategic language that is both universally applicable and capable of engaging in dialog with the world.

Gaining Recognition from International Professional Forces, Co-building a New Global Consulting Ecosystem

Nicholas Warn, Chair of the International Council of Management Consulting Institute, delivered a keynote and expressed his vision for deep cooperation with Apexmind to collaboratively build a global business ecosystem and drive industry evolution. He stated, “What Chinese consultancies can bring to us, particularly consultancies like Apexmind, is an enrichment of what we have already.” This recognition from a global authoritative consulting organization, combined with Mr. Yao’s same-day honor as the IMCHK Honorary Fellow, signals a pivotal shift that Chinese strategy consulting is evolving from a recipient of global business wisdom into a co-creator of original strategic thought systems.

Identifying Seven Strategic Opportunities, Mapping the Growth Blueprint for Chinese Enterprises

Co-President, Apexmind Consulting, Mr. Chen Ji released “Seven Strategic Opportunities for Chinese Enterprises” on site, presenting a structured strategic methodology that provides companies with clear, actionable growth pathways and breakthrough directions. Each opportunity reflects insights refined through real-world strategic engagements with 62 enterprises. These frameworks enable companies to transform external uncertainty into sustainable growth certainty.

From Hong Kong to the World: Powering Shared Growth Across the Greater Bay Area

Distinguished speakers from academia, industry associations, and business communities contributed further insights. Professor Shi Weilei of The Chinese University of Hong Kong, from a global perspective, proposed that the transnational strategy of Chinese enterprises must anchor a balanced core between localization and global collaboration. Mr. Yang Yang, Professor of the Hong Kong University of Science and Technology and Director of HKUST Shanghai Center, illustrated the value driven by disruptive innovation scenarios in smart cities, noting that data and algorithms in the AI era are opening entirely new competitive tracks for global entrepreneurs.

Daniel Chan, President of the Institute of Management Consultants Hong Kong (IMCHK), stated that Hong Kong is upgrading from a “Super Connector” to a “Super Value-Chain Enhancer”. By building a strategic bridge for Chinese enterprises going global and international firms entering the market through two-way empowerment, Hong Kong demonstrates its unique value as a hub. Dr. Huang Weihong, Vice President of The Chinese Manufacturers’ Association of Hong Kong, shared a Hong Kong perspective, interpreting the pathways for brands to achieve strategic breakthroughs in the new consumer wave by leveraging regional advantages and strategic wisdom.

The establishment of Apexmind Consulting Hong Kong Office and the successful conclusion of this summit are a small step in Apexmind’s global journey, but a significant leap for Chinese strategy consulting toward “Cultural Handshake, Strategic Co-evolution”. With a proven track record of enabling 62 enterprises to achieve billion-level growth at scale, Apexmind Consulting continues to drive the industry forward from setting local benchmarks to contributing to global standards. Moving ahead, Apexmind will remain committed to an open vision, bringing strategy frameworks rooted in China and validated through real-world practice to the international stage. In the evolving landscape of global business, Apexmind Consulting is poised to elevate the Chinese consulting industry to new global heights.

Hashtag: #ApexmindConsulting

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/24/connecting-the-world-driving-apex-growth-apexmind-summit-2026-successfully-held-in-hongkong/